Abstract
Nanotechnology is transforming the area of corneal tissue engineering by improving scaffold design and enabling sophisticated therapeutic strategies. Nanomaterials are being used to improve the corneal scaffolds’ mechanical strength, permeability, and transparency, as well as to enable the therapeutic agents’ targeted delivery by nanocarriers. These improvements deal with important problems in corneal repair, like inflammation, infections, and neovascularization. While corneal transplantation remains a standard treatment, the risk of rejection and availability of donor tissue are the main limitations. Recent improvements in electrospinning have made it possible to make nanofibers that look like the natural extracellular matrix (ECM). These fibers have a large surface area and high porosity, which help cells grow, stick to each other, and change into different types of cells. Both synthetic and natural polymers have been successfully employed to fabricate biocompatible and biodegradable nanofibers, indicating their potential for the treatment of various corneal disorders. Electrospun nanofibers are very useful for corneal tissue engineering because they are easy to use, can be used in surgery, and are structurally similar to the cornea. Adding nanofibers and nanoparticles to corneal tissue engineering improves the scaffold and allows for targeted therapies, which means that there are more advanced ways to reconstruct and rehabilitate the cornea. This study investigates the application of naturally derived and synthetic nanoparticles in drug delivery systems and the development of composite nanoparticles, highlighting their potential to improve corneal tissue engineering techniques.
Introduction
The cornea is a multi-laminar, transparent, blood vessel-free structure that reflects light onto the retina while safeguarding the intraocular architecture and milieu.1–3 This tissue is essential for vision. 4 The epithelium (the outermost layer), Bowman’s membrane, the stroma, Descemet’s membrane, and the endothelium (the innermost layer) are the five separate layers that make up the cornea. 5 The human cornea’s thickness is around 500 μm, and the stroma’s keratocytes and collagen fibers form an important portion of the cornea. 6 The epithelium, consisting of five to seven layers, is composed of epithelial cells. 5 Figure 2 illustrates the organized layers that comprise a standard cornea.
Corneal blindness remains a major global health challenge, affecting millions who are in desperate need of transplants, all while we face a serious shortage of donor tissue. Relying on human donor corneas for penetrating keratoplasty brings a host of issues, including logistical hurdles, the risk of immune rejection, and varying quality of grafts.7,8 The most common causes of wounds to the surface of the eyes include systemic disorders, chemically induced burns, trauma, infections, and inflammatory conditions. 9 The last option for severe anomalies is penetrating keratoplasty paired with allogenic tissue transplantation. 10 Although keratoplasty might enhance vision, tissue rejection or inappropriate attachment can cause the treatment to fail. 11
This situation underscores the necessity to create bioengineered alternatives to address corneal issues. Because of these problems, the field of corneal tissue engineering has changed from making simple structural alternatives to making complex, biomimetic constructs that can actively promote regeneration and fix the problems that cause graft failure.12–14 The focus is now on making scaffolds that can do more than just give cells a place to grow; they can also be a local source of therapeutic agents that are released slowly over time. Recently, researchers completed an in-depth study of nanofibers after investigating non-biological substances for corneal repair and wound healing. Recent studies suggest that nanofibers hold promise as a treatment for various types of corneal disorders. 15 To overcome the specific challenges of ocular tissue, it is essential to have mechanical flexibility, permeability to essential nutrients such as glucose, optical clarity, and host tissue integration capacity. Earlier research has indicated that nanofibers play a big role in lowering inflammation, controlling the movement of cells, encouraging cell growth and adhesion, and improving the ability to transport and store things.16–18 Electrospinning is the most common way to make nanofibers. It works with both synthetic and natural polymers.15,16 Synthetic polymers commonly employed in electrospinning include poly(L-lactic acid), poly(lactic-co-glycolic acid), poly(ε-caprolactone), poly(ethylene oxide), and polyvinyl alcohol, while natural polymers include elastin, silk, fibrinogen, collagen, and others. 17 The strength of this technology is rooted in its adaptability; by adjusting factors such as polymer composition, solution viscosity, and electric field, researchers are able to create fibers with regulated diameter, alignment, and porosity. Recent research has shown that nanocomposite scaffolds incorporating graphene oxide and niobium carbide MXene can offer both the essential mechanical strength and bioactivity required to facilitate stromal cell repopulation while reducing fibrosis in vivo.14,18,19 Moreover, the deliberate alignment of nanofibers, as demonstrated in scaffolds designed for stromal regeneration, provides contact guidance that is vital for steering keratocyte phenotype and organizing collagen deposition, which is critical for achieving optical clarity.20,21 Therefore, electrospinning has recently attracted more attention in the fabrication of efficient biomimetic corneal tissue.
Nanotechnology has significantly transformed the delivery of drugs to the eyes. It tackles the common problems we face with regular eye drops, which often have a low effectiveness rate of less than 5% because they become cleared away too quickly and have to overcome various barriers in the eye.14,22 By using systems that incorporate nanoparticles—like polymeric nanoparticles, liposomes, and dendrimers—we can enhance how well these drugs penetrate the cornea, keep them in place longer, and control how they’re released.23,24 This aspect is particularly important for managing issues that can arise after surgery, such as inflammation, infection, and the growth of new blood vessels. For example, if we can control how anti-inflammatory drugs or anti-VEGF medications are released from a scaffold, we could help with the common problem of corneal neovascularization, which can seriously threaten vision because it leads to the growth of new blood vessels.25,26 The research by Zdraveva et al. laid a substantial groundwork by incorporating anti-VEGF into electrospun polycaprolactone (PCL) scaffolds, showcasing improved biocompatibility and support for limbal stem cells. Conversely, the present emphasis is transitioning towards the development of more advanced, stimuli-responsive nanocarriers capable of releasing therapeutic agents in reaction to particular pathological stimuli, such as matrix metalloproteinases (MMPs) found in inflamed environments. 27
This review looks at new developments in polymer nanoparticles and electrospun nanofibrous scaffolds for building corneal tissue. Though these technologies have improved, we still don’t know how to combine them. The primary challenge lies in devising methods to integrate therapeutic nanoparticles with nanofibrous scaffolds while preserving the cornea’s three essential attributes: optical transparency, mechanical integrity, and bioactivity. This review analyzes studies on polymeric nanoparticles (including PLGA, PCL, chitosan, and gelatin) and electrospun polymer scaffolds, assessing their influence on physicomechanical properties and biological effectiveness. This study delineates prospective avenues for the advancement of integrated multifunctional constructs that concurrently function as biomimetic scaffolds and therapeutic nanoparticle carriers.
The cornea: Structure, composition, and function
Hierarchical organization of corneal layers
The cornea is located at the front of the eye and surrounds the iris, pupil, and front chamber. The opaque white sclera marks the edges of this chamber (Figure 1). This clear, avascular tissue lets light through the pupil and into the lens. It also protects against mechanical damage and the entry of germs.28,29 The cornea is the eye’s strongest lens, with a refractive power of about +43 diopters. It also helps light reach to the eye’s internal structures. The average horizontal diameter is between 11 and 12 mm, and the average vertical diameter is between 9 and 11 mm. The thickness is about 0.5 mm, and it becomes thicker as it grows closer to the edges.
30
Schematic representation of the human corneal layered architecture. The illustration delineates the five distinct histological layers of the cornea: the outermost epithelium, Bowman’s layer, the substantial stroma, Descemet’s membrane, and the innermost endothelium.
The cornea is a thin but complex tissue made up of many layers that serves optical, protective, and mechanical purposes. It is typically divided into five parts: the corneal epithelium, Bowman’s layer, stroma, Descemet’s membrane, and endothelium. 29 Each region has its cells and extracellular matrix, as well as its own physiological functions. Together, these things ensure that the cornea stays clear and works together.
The corneal epithelium is made up of non-keratinized, stratified squamous cells that act as the first line of defense against outside threats. The limbal region mainly feeds these cells. It has epithelial stem cells that help the corneal surface stay fresh. Basal cells proliferate and differentiate into wing cells, which then migrate to the ocular surface and further differentiate into superficial flat cells, enabling epithelial renewal approximately every 7 days. 31 The XYZ hypothesis describes this process: X represents the proliferation and stratification of basal limbal cells, Y indicates their centripetal migration, and Z pertains to the desquamation of superficial epithelial cells. 32 Tight junctions between epithelial cells and their connection to the basement membrane make a strong barrier against chemicals, microorganisms, and water. This keeps the epithelium clear and intact. Molecular signaling between the epithelium and stroma, facilitated by growth factors and paracrine molecules, is essential for maintaining structural and functional stability, in addition to its protective roles. The epithelial surface is covered by a tear film. It keeps the surface from drying out, helps move oxygen and nutrients, and protects the body from disease. The delicate interaction among stem cells, surface cells, basement membrane, and tear film facilitates swift tissue regeneration, protective mechanisms, and biochemical homeostasis, establishing a basis for corneal tissue engineering.33,34
Bowman’s layer is an acellular structure that lies beneath the epithelium. It is made up of a dense network of collagen fibrils and extracellular matrix (ECM). Proteoglycans and collagen types I, III, V, and VII make up the matrix. These are randomly spread out in a framework that is not well-defined. Bowman’s layer connects the epithelium to the stroma, which is a mechanical function. By making it easier for stromal collagen fibrils and keratocytes to interact, this process improves the shape and strength of the corneal anterior. Unmyelinated nerve axons go through the structure, which helps separate the epithelium from the stroma. 35 The intervention speeds up the healing of the stroma after photorefractive keratectomy and helps the epithelium grow back, which is important for corneal regeneration. Structural changes in Bowman’s layer, seen in keratoconus, are linked to less clear corneas. This phenomenon shows how important it is to accurately copy its physical and chemical properties in engineered corneal scaffolds. Bowman’s layer becomes thinner as you grow older, probably because of natural processes that break down or cross-link collagen. There is no regeneration after an injury, and any replacement happens slowly, which often leads to a structure that is different from the original. Bowman’s layer is a mechanical barrier and structural integrator that is crucial for keeping the cornea clear and working.36,37
The stroma, which is the thickest layer of the cornea, makes up more than 90% of the cornea’s weight. It is made up of type I collagen fibers that are arranged in parallel layers. For optical transparency, the collagen fibrils need to be arranged in a certain way, and proteoglycans like lumican, keratocan, and decorin need to be present. Because the cornea has a hierarchical structure that goes from the nanoscale to the macroscale, it can stay clear. This structure also provides the cornea the mechanical strength it needs to stay healthy. The replication of this highly organized architecture in synthetic scaffolds remains a substantial challenge in corneal tissue engineering.38,39
At the posterior region of the cornea lie Descemet’s membrane and the endothelium. Descemet’s membrane is a special basement membrane for endothelial cells. These cells control the hydration of the stroma by using ionic pumps, which keeps the cornea clear. 40 Since endothelial cells in the adult human cornea have very limited proliferative capacity, any damage to this region can lead to corneal edema and visual impairment. Consequently, restoring endothelial pump function is a critical objective in advanced corneal tissue engineering research. 41
The cornea is a multilayered structure with a complex and organized architecture. This is because the cellular parts, structural proteins, and extracellular matrix all work together in a coordinated way. This integrated system makes sure that the cornea is clear, strong, and safe, which shows how complicated it is to make copies of it for regenerative purposes.
Key cellular components and their roles
The cornea can heal and work properly because different types of specialized cells are spread out across its layers and work together in a precise way. These cells not only keep the cornea clear and strong, but they also help the body heal after an injury and keep the immune system in balance. To make tissue-engineered scaffolds and identify new ways to treat corneal damage, you need to know where each type of cell comes from, what it does, and what its properties are.42,43 Studying epithelial, stromal, endothelial, stem, and immune cells and how they work together presents us important information about how regeneration works and how to improve engineered corneal models.
Corneal epithelial cells, which come from limbal stem cells, make up the outermost layer of the cornea. These cells are the first line of defense against damage from the environment, microbes, and physical forces. They also control how cells grow and move, which lets the epithelium keep renewing itself. They release growth factors like EGF, TGF-β, and NGF, which work with stromal cells and the basement membrane to help repair tissue while also supporting the stromal keratocytes and the corneal nerve network.44,45
Stromal keratocytes are the main type of cell in the stroma, and they come from mesenchymal tissue. Keratocytes, in normal circumstances, remain inactive and help the cornea stay clear and strong by making type I and V collagen and proteoglycans like decorin and lumican. When keratocytes are hurt or inflamed, they become active and change into fibroblastic or myofibroblastic phenotypes. These cells help change the extracellular matrix. However, prolonged activation may lead to scarring or stromal opacity. 46
During embryonic development, endothelial cells come from the inner ocular layer and are found on Descemet’s membrane. These cells control the hydration of the stroma through Na+/K+-ATPase pumps and aquaporin channels, which are necessary to keep the cornea clear. Restoration of endothelial function often requires bioactive scaffolds or cell-based therapies because endothelial cells don’t divide very well. 45
Limbal stem cells, located at the corneoscleral junction, are the primary source for epithelial regeneration. They come from mesenchymal and embryonic sources and can turn into mature epithelial cells. When these cells are harmed, the epithelium doesn’t work as well, and the cornea isn’t as clear. To keep their regenerative phenotype and function, they need artificial microenvironments and bioactive biomaterials like hydrogels and amniotic membrane. 47
Resident immune cells, including dendritic cells, macrophages, and memory T lymphocytes, originate from the bone marrow and mesenchyme. Under physiological conditions, they maintain immune homeostasis and, upon injury or infection, activate inflammatory pathways. They play essential roles in pathogen clearance, tissue repair, and immune regulation. Tissue-engineered scaffolds must be designed to support controlled immune responses.48,49
Corneal nerves and Schwann cells, which come from the trigeminal nerve, work closely with the epithelium and keratocytes. Neuropeptides such as Substance P and CGRP are released to encourage the regeneration of epithelial tissue, while the epithelium produces neurotrophic factors that support the survival of neurons. The reestablishment of neural networks within engineered scaffolds is a pivotal marker of functional corneal regeneration. 50
The endothelial cells of limbal blood vessels, derived from embryonic endothelium and mesenchymal cells, perform nutritive and regulatory functions within the corneal microenvironment. In pathological conditions, they can promote neovascularization, potentially impairing corneal clarity. When making scaffolds to stop unwanted vascularization, two important things to do are to control VEGF expression and raise the levels of anti-angiogenic factors.
Corneal stromal stem cells (CSSCs), located in the anterior stroma and encircling the limbus, derive from mesenchymal tissue. These cells can become keratocytes or epithelial cells. Research on animals has shown that they can repair corneas without leaving scars. Corneal stromal stem cells constitute a viable cellular source for corneal tissue engineering. 51
In short, the coordinated work of all these cell types makes a dynamic network that keeps the cornea clear, helps it heal, and keeps the immune system in check. One of the main goals of corneal tissue engineering is still to recreate these cellular interactions in artificial settings.
The corneal extracellular matrix as a blueprint
The corneal extracellular matrix (ECM) is a complex and well-organized network of fibrillar and non-fibrillar molecules that are needed to keep the cornea’s shape, transparency, and mechanical stability. This system serves as a basis for designing scaffolds for tissue engineering. Most of the stromal extracellular matrix is made up of type I and V collagens. The type I and V collagens are arranged in parallel, highly organized lamellae. This setup provides strength and flexibility to the structure while letting in as much light as possible and cutting down on scattering. Type VI collagen surrounds keratocytes, which helps cells talk to each other and keeps the tissue’s structure.52–55
Decorin, lumican, keratocan, and mimecan are all types of stromal proteoglycans that are important for controlling the stroma’s thickness and hydration. This is because they can absorb water and interact with collagen fibrils. These molecules serve not only a structural function but also participate in cell signaling through interactions with integrin receptors and growth factors. This process changes how keratocytes and stromal stem cells grow and work.54,56
The epithelial basement membrane, which is made up of laminin, nidogen, perlecan, and fibronectin, holds the epithelium to the stroma and helps it heal after an injury. This membrane sends biochemical signals and growth factors to epithelial cells, which helps them stay alive and grow. 57
Type VIII collagen and endothelial-specific proteoglycans in Descemet’s membrane are crucial for keeping the endothelial layer stable and the stroma hydrated. This unique ECM composition allows endothelial ionic pumps to work well in normal conditions, which keeps the cornea clear. 58
The ECM is made up of structural elements, growth factors, cytokines, and signaling molecules that work with stem cells and keratocytes to start the processes of regeneration and repair. Pathological changes in the extracellular matrix, including heightened myofibroblast activity, proteoglycan degradation, and disorganization of collagen structure, can result in opacity, scarring, and compromised corneal function. 59
The corneal extracellular matrix serves as a mechanical and optical framework while also establishing a crucial microenvironment that influences cellular behavior, facilitates tissue healing, and maintains corneal clarity. This is a key framework for making scaffolds for tissue engineering and finding ways to treat problems with the cornea.
Target properties for an engineered corneal construct
To make a successful engineered corneal construct, a lot of different criteria must be met. This section lists important traits, such as excellent optical clarity for light transmission, strong mechanical integrity to withstand surgical manipulation and intraocular pressure, biocompatibility to support cellular activities without causing an adverse immune response, appropriate permeability for nutrient diffusion, and controlled biodegradability that matches the rate of host tissue regeneration. The primary objective is to develop a multifunctional construct that serves as a physical scaffold while simultaneously promoting the regenerative process (Figure 2). Schematic illustration of the characteristics of bio functionalized electrospun nanofibrous scaffolds for corneal regeneration.
Optical clarity and light transmittance
The cornea is the main part of the eye that reflects light, and its flat surface is important for clear vision. 60 In cornea tissue engineering, particularly for corneal wound dressings and stromal regeneration, it is imperative to maintain the cleanliness of nanofibrous scaffolds. 61
Transparency is contingent upon various design elements, including the reduction of scaffold thickness and the utilization of polymers with refractive indices closely matching that of the human cornea.61,62 Himmler et al. indicated that electrospun scaffolds measuring 10 µm in thickness demonstrated transmission rates between 15% and 75%, contingent upon the fiber diameter. The alignment of smaller fiber diameters with the refractive indices of both the medium and the fibers resulted in significantly enhanced light transmission. 61 Electrospinning presents numerous benefits, such as high output, affordable prices, and a simple, straightforward process. It contributes to developing ECM-like three-dimensional fibrous structures with aligned fibers that improve cell phenotype, migration, and proliferation. 63 Nonetheless, restricted light transmission is a barrier owing to the short interfiber spacing in synthetic polymer fibers. 63
Refraction is influenced by the refractive indices of both the cornea and the tear film. The human cornea generally possesses a refractive index of 1.376 across the visible spectrum of the eye. 64 Engineered scaffolds must protect internal ocular tissues from UV radiation and pathogens, provide sufficient strength to endure intraocular pressure, and permit the diffusion of nutrients and oxygen to achieve a comparable refractive index. 65
Alignment of fibers is necessary for cell growth, as fiber contact guidance is compatible with cell morphology and cytoskeletal stress in engineered scaffolds. 66 Kang et al. created decellularized squid mantle scaffolds that maintained alignment and transparency through the CUBIC process. The scaffolds demonstrated biocompatibility, facilitated corneal cell proliferation, and exhibited effective integration in vivo, indicating potential for structured corneal regeneration. 67 Tayebi et al. observed that the incorporation of chitosan nanoparticles (CSNPs) into chitosan/PCL scaffolds enhanced their optical transparency and wettability. The CSNP/PCL 50/25 formulation attained the optical transparency comparable to that of human acellular corneal stroma and minimum water contact angle. 68 Zhang et al. proved that electrospun collagen nanofibers (eCFs) increased corneal healing by inhibiting inflammation, promoting cell proliferation, and reducing fibrosis; in vivo, they promoted epithelial wound healing without compromising transparency, thereby proving their viability for optical-functional regeneration. 69 Zargar et al. developed multilayered nanofibrous scaffolds incorporating collagen, aloe vera, silk fibroin, and epithelial growth factor. The three-layered electrospun/electrosprayed configuration possessed appropriate thickness, structure, and mechanical strength, all of which were also tunable. In vitro assays depicted that the cells possessed greater adhesion, longer viability, and improved differentiation, which proves that the cells are capable of corneal epithelium regeneration. The confirmation was established through scanning electron microscopy. 70
Optical transparency in corneal tissue engineering demands stringent control over fiber diameter, alignment, and refractive index matching. Hybrid nanofibrous scaffolds made of natural polymers and synthetic polymers, such as chitosan/PCL and collagen-based systems, are the optimal technique for achieving functional transparency and biocompatibility within the engineered corneal substitutes.
Mechanical integrity and suture retention
Biomaterials analogous to corneal stroma can be synthesized using vitrification, a regulated dehydration technique. These materials exhibit elevated collagen concentration and alignment, enhancing their mechanical strength and compatibility for in vivo implantation with simple interrupted sutures. 71 Peng et al. created graphene oxide/niobium carbide nanocomposite scaffolds with adequate mechanical strength and stability. These scaffolds have the potential to be strong and bioactive substrates for corneal tissue applications. They demonstrate its potential for increasing the number of stromal cells in vitro and lowering inflammation and fibrosis in vivo. 72 Through modifications to the annealing and manufacturing processes, Beena et al. improved silk fibroin sheets for corneal engineering. The films presented were compelling, mechanically sound options for corneal rehabilitation, demonstrating varying tensile capacities and degradation rates influenced by the solvent and processing conditions, while consistently preserving structural integrity, biocompatibility, and optical clarity. 73 Jung and others created three-dimensional electrospun keratin/PVA nanofiber membranes to implant/transplant in the cornea. The three-dimensional structure was stronger, clearer, and more compatible with organisms than the two-dimensional versions. 74 Kung et al. (2016) enhanced the assessment of suture retention strength for ocular scaffolds through the utilization of polycaprolactone (PCL) films and amniotic membranes. Their modified test precisely assessed resistance to suture pull-out, deformation under maximum load, and rupture. This method reliably assesses the mechanical strength and surgical handling of corneal biomaterials. 75
An appropriate corneal scaffold must replicate the mechanical characteristics of a healthy cornea while ensuring biocompatibility, optical clarity, surgical stability, and non-immunogenicity. 76 In 2022, Himmler et al. created electrospun nanofibrous structures with fiber diameters ranging from 35 to 549 nm. To augment the regenerating capabilities of the structures, heparin or hyaluronic acid coatings were subsequently applied in a methodical layer-by-layer manner. Scaffolds featuring 113 nm fibers exhibited enhanced drug-loading capacity and suture retention, indicating their potential as biomimetic alternatives to traditional amniotic grafts. 77
In conclusion, achieving adequate mechanical integrity and suture retention in engineered corneal structures requires the modification of fiber diameter, hierarchical organization, and interfacial chemistry. Nanocomposite and electrospun 3D structures, particularly structures that utilize hybrid natural-synthetic polymers, can demonstrate a favorable use of mechanical strength while retaining transparency and biocompatibility within the operating room and while healing.
Biocompatibility and bioactivity
Corneal regeneration biomaterials must possess excellent mechanical stability, regulated biodegradability, transparency, and satisfactory biocompatibility. Nanotechnology has made corneal scaffolds more compatible and biologically effective, which has improved cell connections and decreased the risk of inflammation.78,79 The protective barriers on the surface of the eye allow less than 5% of the active chemicals in eye drops to reach the interior tissues. Due to this issue, researchers are exploring both traditional and innovative methods for medication delivery. Nanoscale carriers have demonstrated superior efficacy in overcoming corneal permeability issues and enhancing ocular bioavailability. 80 Selecting an appropriate scaffold material is crucial for the long-term success of corneal endothelial tissue engineering and transplantation. Biocompatible and bioactive substrates that enhance endothelial cell adhesion, proliferation, and phenotypic maintenance are essential in ensuring effective regeneration. 81 Nanofibers have been extensively utilized in healthcare environments due to the fact that they consist of biocompatible materials. They are also utilized for drug delivery and tissue engineering. Two of the greatest strengths for ophthalmology are their capacity to deliver sustained release of drugs and their application in research involving corneal tissue. 82
Biocompatible nanoadhesives have been produced employing biomimetic materials from tissue engineering, leveraging cell adhesion, proliferation, and development throughout the healing process. These nanoadhesives facilitate the closure and healing of ocular tissues. 83
Ultimately, the application of nanotechnology techniques, particularly through biomimetic polymers and nanofibers, synergistically enhances the bioactivity and biocompatibility of corneal scaffolds. Corneal substitutes derived from these pharmaceuticals safely and successfully replicate the characteristics of the original tissue by gradually degrading, releasing medications into the surrounding environment over an extended period, and improving the connections between cells and the matrix.
Permeability and nutrient diffusion
The eye surface acts as a complex biological barrier that prevents the majority of therapeutic agents from achieving clinically relevant penetration, which indicates that larger total doses should be given on a continuous basis. Conversely, inadequate efficacy and adverse effects are prevalent consequences of this method. The enhanced ocular permeability, retention time, and overall pharmacokinetic efficacy of nanoparticle-based approaches render them a viable alternative. 84 Drug delivery through nanocarrier-mediated drug delivery systems offers targeted therapeutic effect, sustained release, and improved bioavailability; facilitated ocular barrier penetration and reduced systemic exposure are also offered. 85 A nanosponge, a product of β-cyclodextrin crosslinking with diphenyl carbonate, is one such system. This technique normally yields low efficiency and unnecessary side effects. Nanoparticle-based strategies present a promising alternative with their increased ocular permeability, increased residence time, and improved pharmacokinetic behavior. 84 The ideal scaffold for corneal regeneration would be able to exhibit flexibility, mechanical durability, moisture retention, and enhanced transparency to replicate the two-dimensional lamellar architecture of the natural cornea. The substrate must possess appropriate porosity to facilitate food and oxygen penetration, appropriate oxygen permeability to support cellular viability, and a controlled disintegration rate that promotes tissue remodeling without inflammation. 70 Nanotechnology in ocular engineering applies physical and chemical advancements in designing surfaces for promoting cellular adhesion and growth. This technology constructs microenvironments that enable the accelerated delivery of nutrients to cells. 86
In conclusion, making the scaffold more permeable and allowing nutrients to spread through it is important for keeping eye cells alive and helping tissue grow back. The combination of nanocarrier-mediated delivery and nanostructured scaffolds effectively circulates around diffusion barriers, making sure that oxygen and nutrients are delivered to the right places and stay there for a long time.
Biodegradability and integration with host tissue
Biodegradability is an essential criterion for corneal endothelium implants, guaranteeing that the scaffold degrades at a regulated rate in alignment with the regeneration of Descemet’s membrane to prevent detrimental ocular consequences.87,88 Numerous natural biomaterials exhibit inherent biodegradability; nonetheless, their degradation rates may require modification. For instance, gelatin is rapidly degraded by enzymes, resulting in diminished long-term stability within the eye. 88 Synthetic polymers allow for precise control over composition and degradation rate, providing customizable performance according to the needs of corneal repair. 87 Kuragel, a hydrogel composed of gelatin and hyaluronic acid, was gradually degraded by enzymes, retaining around 69% of its mass after 1 month in an enzymatic environment. This ensured that the matrix was sufficiently stable to facilitate the regeneration of corneal tissue. 88 Furthermore, poly (lactic-co-glycolic acid) (PLGA) membranes, a recognized biodegradable copolymer, were successfully utilized on rabbit corneas and exhibited total degradation after 29 days. 89 However, excessive or uncontrolled degradation in similar polymeric materials may lead to medium acidification, compromising cell viability and inducing local inflammation.90,91 Individuals commonly utilize polycaprolactone (PCL) due to its gradual degradation. When combined with other polymers such as chitosan in composite scaffolds, it can alter the degradation rate.87,92,93
Biomaterials must exhibit biocompatibility and possess sufficient adhesive strength to be incorporated into host tissues without sutures. 87 Kuragel was designed for sutureless integration and bioadhesion. Its adherence involves covalent bonds between methacrylate groups in the hydrogel and thiol groups on the wound surface. 88 LC-COMatrix hydrogel reached a burst pressure of 542 mmHg, enabling seamless tissue merging in rabbit models.94,95 Nevertheless, certain synthetic polymers, such as poly(hydroxyethyl methacrylate) (PHEMA), have been associated with the recruitment of inflammatory cells in vivo, which can impede regeneration.96,97 Kuragel was engineered for bioadhesion and integration without the necessity of sutures. The adhesion results from covalent interactions between methacrylate groups in the hydrogel and thiol groups on the wound surface. 88
The optimal equilibrium between biodegradability and tissue integration is crucial for effective corneal regeneration. Hydrogels and polymeric composites that degrade in alignment with natural tissue remodeling, while maintaining adhesion, transparency, and bioactivity, provide a viable approach for sutureless, regenerative corneal replacement. The integration of visual, mechanical, and biological components underpins successful corneal regeneration. Electrospinning offers a versatile technique for fabricating nanofibrous scaffolds that effectively replicate the native architecture of the cornea to meet these diverse requirements.
Electrospinning for fabricating biomimetic corneal scaffolds
Fundamentals of the electrospinning process
Over the last several years, electrospinning has become the most widely used method for producing nanofibers. This technique utilizes electrostatic forces to extrude fibers from a polymer solution through a spinneret. The fundamental principle of electrospinning involves the administration of high voltage, which imparts an electric charge to the polymer solution and results in the establishment of a structure called the Taylor cone. A delicate stream of solution is discharged from the apex of the Taylor cone when the electrostatic forces overcome the solution’s surface tension. This jet travels along the electric field and deposits it onto a grounded collector, forming nanofibers. The process is affected by multiple parameters, including the conductivity and viscosity of the polymer solution, the imposed voltage, the space separating the collector and the needle tip, and the solution flow rate. Figure 3 depicts the electrospinning setup that produces nanofibers on a revolving drum. Schematic diagram of a basic electrospinning setup. The illustration depicts the core components, including the syringe pump, spinneret, high-voltage power supply, and collector. The process begins with the formation of a Taylor cone at the needle tip, leading to the ejection of a polymer jet that thins and solidifies into nanofibers deposited on the collector.
One of the most intriguing benefits of the electrospinning procedure is the capacity to control the scaffold’s porosity and thickness. It can precisely and accurately create fibers with sizes spanning from 50 to 100 nm or larger, and it comes with an effortless experimental setup. The resultant nanofibers will be very porous and have a large surface area. Inside the scaffold, porous structures facilitate optimal cell interaction; wide pores limit cell attachment due to their reduced area, while small pores restrict how deeply cells can penetrate. Proper porosity facilitates vascularization, metabolite transfer, and cell division. Scanning electron microscopy (SEM) and mercury porosimetry are two methods utilized to study the scaffold’s porosity. Manufacturing-oriented nanofibers are an undeniable benefit of electrospinning over alternative manufacturing methods. Commercial applications for scaffolds and fibers created from electrospinning are numerous and include the creation of polymeric separation membranes, fibers as reinforcing agents in composite materials, nonwoven fabric substitution, and other biomedical applications.98–101 Figure 4 shows the basic way that electrospun scaffolds interact with corneal cells. This diagram shows a three-dimensional nanofibrous network that has been improved with important adhesion proteins like fibronectin and collagen. These proteins replicate the structure of the natural extracellular matrix. The picture shows how these proteins act as ligands for integrin receptors on the surfaces of endothelial cells, keratocytes, and epithelial cells. This interaction makes it easier for important intracellular signaling to happen, which controls adhesion, proliferation, and phenotypic maintenance. All of these are necessary for successful corneal regeneration. Schematic of corneal cell interaction with electrospun nanofibrous scaffolds. This figure shows how corneal cells (epithelial, stromal, and endothelial) bind to adhesion proteins attached to the nanofibers through integrin receptors. This binding leads to the activation of intracellular signaling pathways and regulates the processes of cell adhesion, proliferation, and differentiation. Furthermore, the controlled release of growth factors or drugs from nanoparticles in the scaffold provides a biological and therapeutic environment for corneal regeneration.
Because of its close similarities in structure to the native extracellular matrix (ECM), elevated porosity, and high ratio of surface area to volume, all of which support motion, proliferation, differentiation, and cell adhesion, in addition to its unique mechanical properties, simplicity of adjusting fiber properties, excellent handling, and suturability for implantation, electrospinning has attracted more interest recently in the fabrication of biomimetic efficient corneal tissue. 102
Material selection: Natural & synthetic polymers
The shape of the electrospun fibers is significantly influenced by both the molecular weight of the polymers and the concentration of the polymer solution. The diameter of the electrospun fibers typically demonstrates a favorable association with the concentration of the solution, assuming all other parameters are held constant. Bead formation, or the incapacity to create fibers, may stem from an improper concentration. Scaffolds featuring different fiber configurations can be efficiently and swiftly produced to replicate the structure of the extracellular matrix (ECM) found in authentic corneal tissue (for example, fibers in the corneal stromal layer that are lined together) through the manipulation of the electrospun collector or the electrostatic field. The structure, fiber configuration, surface chemical modification (for example, plasma), and information molecules (for example, epidermal growth factor) can all influence how well electrospun scaffolds work. Through regulating these variables, scaffolds with superior qualities (for example, mechanical, biological, and high transparency) can be created that enhance corneal cell adhesion, movement, proliferation, and differentiation in addition to promoting the development of corneal tissue. 103 For corneal tissue engineering, natural materials with high biodegradability, biocompatibility, and low immunogenicity, like collagen, gelatin, and silk, have been widely used.104,105 But natural polymers are used together with a synthetic polymer for electrospinning due to their low strength. 106 In this section, we discuss studies that have used natural polymers in corneal repair.
Gelatin
Since gelatin is a kind of collagen that has been hydrolyzed, the primary component of the cornea, it is one of the biomaterials that might be used for producing corneas. Gelatin’s affordability, biocompatibility, and biodegradability make it an attractive biopolymer. Furthermore, gelatin promotes the growth, development, and multiplication of cells and has no negative or toxic effects on them. 107 The considerable degradability and instability of gelatin biopolymers after long incubation in a physiologic aqueous environment are their limitations. 108 Ajay Kumar Sahi et al. fabricated silk fibroin/gelatin by the electrospinning method for corneal regeneration. In this study, it was mentioned that the scaffold that was penetrated with gelatin (in formic acid) had the maximum transparency of all the manufactured samples, measuring 77.75 ± 2.3%. This is like the transparency of the natural cornea (about 70% to 90%) with normal acute vision. The findings indicate that a gelatin-permeated (in formic acid) composite scaffold is a superior choice for an analog of the corneal stroma, as it has the advantages of both gelatin and silk, including enhanced stability, enhanced cytocompatibility, and optimal transparency. In another investigation, K. Tonsomboon et al. presented alginate-based scaffolds incorporating gelatin nanofibers for corneal tissue engineering. This study demonstrates how non-immunogenic natural polymers are accessible and cheap and may be used to create transparent nanofiber-reinforced hydrogels that mirror the cornea’s microstructure. Gelatin nanofibers were created via electrospinning, and alginate hydrogels were subsequently added into them. Hydrogels’ mechanical qualities were enhanced by almost an order of magnitude when electrospun nanofibers were added, creating composites with strong mechanical characteristics. 109
Collagen
Collagen, the primary natural polymer of the corneal stroma, has exceptional biocompatibility. 110 Because of its biological qualities and flexibility, collagen can be utilized to create scaffold material for tissue engineering and implantable devices in dentistry and medicine.111–113 Due to its inadequate mechanical qualities, collagen membrane is currently not widely used as a material for corneal repair. 114 The application of collagen membranes for corneal regeneration is restricted to prevent bacterial infections following keratoplasty, even though collagen can promote bacterial development.110,115 In a study, collagen nanofibers were fabricated with acetic acid solvent and the electrospinning method. These nanofibers lead to biocompatibility, decreased expression of the myofibroblast phenotype on the linked scaffold, and collagen type I fibers that mimic the distinct structure and configuration of these fibers in the natural cornea. 116 In another study, A. Acun et al. synthesized collagen with hexafluoroisopropanol (HFIP) and dimethylformamide (DMF) solvent and an EDC cross-linker, and the authors ultimately reached the conclusion that their research produced high transparency (∼80%) and increased ECM deposition that are conducive to cell adhesion and proliferation. 117
Silk fibroin
In addition to its widespread availability, affordability, and demonstrated biocompatibility, silk fibroin is an intriguing biomaterial because it can be quickly formed into a wide range of both 2D and 3D structures and may be “tuned” to the specific needs of a stem cell niche by decorating it with extracellular matrix (ECM) proteins and different growth factors.118,119 Furthermore, this work expands on a number of recent investigations into the usage of silk fibroin as a corneal cell substrate.120–122 Esmaeil Biazar et al. 123 synthesize silk nanofibers with the electrospinning method. Silk using the same proportions (2.5% w) was dissolved in a solution of trifluoroethanol, and a glass syringe with a syringe pump was filled with the final solution. Microscopic examinations demonstrated that the human limbal stem cells maintained a typical corneal stem cell phenotype and were securely attached to the substrates. Microscopic examinations demonstrated that cells effectively penetrated the nanofibers to create a 3-dimensional corneal epithelium that remained alive for fifteen days. Narges Forouzideh et al. inserted epigallocatechin gallate (EGG) into electrospun silk fibroin in another experiment to confer anti-angiogenic properties to tissue-engineered corneal constructs. For the preparation of electrospun silk fibroin, relative humidity and temperature were 35 ± 5% and 25 ± 5°C, respectively. Pure formic acid (10–16%) was used to dissolve the lyophilized silk while being stirred magnetically at ambient temperature. The solution was placed into a polypropylene syringe that was attached to an elevated-voltage (24 kV) source and pumped via the syringe at an average 0.1 mL/h rate to perform electrospinning. Scanning electron microscopy proved that the scaffold was appropriate for supporting limbal cells. Drug loading into the scaffold in situ effectively created a uniform nanofiber structure. 124
Chitosan
Because of its particular biological and biochemical features, chitosan is one of the best polysaccharides that might be used as a scaffold. It is also frequently utilized in the tissue engineering, pharmaceutical, and industries related to food. Chitosan makes an outstanding substrate for cell proliferation and attachment because of its biocompatibility, biodegradability, aqueous solubility, antifungal and antibacterial activity, mucoadhesive characteristics, and homeostatic characteristics. 125 Since chitosan has extremely low spinability, researchers routinely utilize additional polymers, such as collagen, to make chitosan more spinable. The electrospun chitosan-collagen (CC) nanofibrous scaffolds have an opportunity to be utilized in ocular tissue engineering. The mechanical and optical properties of the composite CC scaffolds were superior to those of chitosan alone. It has been observed that adding collagen enhances both mechanical and physical characteristics (including hydrophilicity and clarity of vision) without lowering biocompatibility. Additionally, CC scaffolds demonstrated encouraging properties to facilitate proliferation, cell adhesion, and survival and have been suggested as a suitable option for applications involving the regeneration of ocular tissue. 126
Cellulose
Bacterial cellulose (BC) is a polymeric scaffold that is created by the bacterium Gluconacetobacter xylinus. Its characteristics include semi-transparency, hydrophilicity, flexibility, and semipermeability, which enable its utilization in tissue engineering. 126 According to Chen et al. and Yadav et al., BC is not biodegradable in animal tissues and is biocompatible, making it a potentially desirable polymer for the integration of products for corneal purposes. But BC has low transparency and is inflexible.127,128 Therefore, it has been suggested that polycaprolactone (PCL) be added to BC scaffolds to improve BC’s mechanical and optical properties and prepare it for corneal implantation.
Hyaluronic acid
Hyaluronic acid, or HA, is a polysaccharide that is a member of the glycosaminoglycan class. Units of N-acetyl-D-glucosamine and glucuronic acid alternate to form the HA molecule. In vertebrates, HA can be found in almost every type of tissue. The molecular weight of HA can reach several million. Among the biological materials, hyaluronic acid is frequently utilized for tissue engineering. For instance, HA has been deeply examined for possible use as a wound dressing. Because HA contains many functional groups, various physical and chemical approaches can be employed to cross-link it. Because HA may stimulate the differentiation and migration of epithelial and mesenchymal cells, it can be applied to tissue repair. Because of its biological characteristics, HA is an excellent material for tissue engineering. 129
Hyaluronic acid, referred to as hyaluronan (HA), offers numerous benefits for use in corneal wound healing; however, due to its prominent surface tension and high viscosity, even at low concentrations, this polymer cannot be electrospun in its native state on its own. 130 Researchers usually use other polymers, like PCL, to improve the spinability of hyaluronic acid to get around its spinability concern. In accordance with the Marcus Himmler study, layer-by-layer (LbL) technology was utilized to construct electrospun scaffolds with PCL-HA fiber diameters of 167, 549, 113, and 35 nm. The scaffolds were treated with hyaluronic acid to promote ocular tissue regeneration following surgery. 131
HA-synthesized nanoforms have a few drawbacks, including poor mechanical strength and fast in vivo degradation. These limitations can be mitigated through chemical modification or crosslinking, which enhances the material’s biological, mechanical, degradative, and viscosity qualities. Three specific locations are being modified: the carboxyl, hydroxyl, and -NHCOCH3 groups. The carboxyl group can be covalently modified to form amide bonds using carbodiimides or carbonyl diimidazole; the hydroxyl group can be modified to form ethers, esters, hemiacetals, and oxidations; and –NHCOCH3 can be modified by amination, deacetylation, hemiacetal formation, and deacetylation. 132
Applications of synthetic nanofibers in corneal tissue repair
Several synthetic polymers and their uses in corneal tissue engineering with electrospinning methods.
The crucial aspect of corneal implants in tissue engineering is the scaffold’s transparency, so the method of electrospinning for corneal tissue engineering and the choice of material are so important to making a transparent layer.106,138 Therefore, in this section, we will look at several FDA-approved polymers utilized for the repair of the cornea. In some cases, they are used solely, but in most of the studies, they were used in blending with other polymers.
Polycaprolactone (PCL) is a synthetic polymer for medical use because it is biocompatible and biodegradable. The intrinsic properties of PCL include its ability to produce nanofibers, which make it suitable for medical applications. The benefits of the nanofibers include a wide surface area, minimal pore diameter, and elevated porosity. 139 The PCL nanofibers possess the capacity to promote the growth and attachment of limbal epithelial cells while maintaining their original characteristics. Moreover, these nanofibers can be utilized for the regeneration of impaired ocular surfaces. 139 Additionally, PCL-based scaffolds can serve as a substitute substrate for scaffolds made from the human umbilical cord and can be a helpful option in ocular surface tissue engineering. 140 Human corneal cells easily adhered to PCL-based nanofibers and demonstrated excellent adhesion and proliferation. The cells showed growth on aligned matrices, suggesting that the matrices effectively supported the expansion of corneal cells. These findings confirm the potential of the matrices as substrates for biomedical purposes. 141
Poly(L-co-D, L-lactic acid) (PLDLA) is a significant biomaterial due to its biocompatible features that encourage cell renewal and proliferation.102,142,143 The electrospun-aligned PLDLA scaffolds, when cultivated with human corneal stromal cells, exhibited changes in matrix elasticity (elastic modulus) and dimensions, leading the cell phenotype to change from fibroblasts that are actively contracting to quiescent keratocytes. 1 Serum-free medium and insulin supplementation have been demonstrated to alter the activity of mature human-derived corneal stromal cells in three-dimensional PLDLA multi-layered structured constructions, causing corneal fibroblasts to revert to keratocyte characteristics in a three-dimensional structure. 102
Due to its advantageous properties, polylactic-co-glycolic acid (PLGA), a polymer that is biodegradable and developed through synthetic processes, has been extensively studied in the area of regenerative medicine. 144 Furthermore, owing to its highly responsive behavior towards stimuli, it is also recognized as a variant of an intelligent polymer. 145 This polymer is employed in PLGA-derived drug delivery strategies for the management and detection of certain illnesses.146,147 Furthermore, this compound has been utilized in the area of regenerative medicine and has received investigation for its applications in corneal regeneration. 144 The electrospun PLGA scaffold as a substitute for amniotic membrane in ocular surface regeneration may offer assistance for corneal epithelial stem cells and act as a protection against infectious diseases. 148 A suitable carrier for Limbus stromal cells was applied with a combination based on PEGDA (poly(ethylene glycol) diacrylate) and then electrospinning of PLGA (poly(lactic-co-glycolic acid)) on it using a mix of stereolithography and electrospinning techniques. LSCs could easily adhere to and grow on PLGA sheets and induce epithelization in an ex vivo environment. 149
PHBV (poly-3-hydroxybutyrate-co-3-hydroxyvalerate) belongs to the polyhydroxyalkanoate family. This material is a category of natural polyesters that can be obtained as by-products of microorganisms under specific circumstances with a supplementary carbon source. These polymers are promising materials to produce materials with biological applications. The large number of monomers in this group of materials allows changes to be made in their polymer and copolymer structure, which allows the production of copolymers with different compositions and ratios. 150 Drug screening laboratory procedures offer expedited and efficient data analysis, resulting in a major decrease in animal sacrifices. Most of these methods use biomaterials that have been investigated in the cornea field, like PHBV (poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid)) and PHB (polyhydroxy butyrate). 151 Some studies have shown that human limbal stem cells (LSC) were able to maintain a typical corneal stem cell characteristic and remain tightly bound to the PHBV substrates. These cells have permeated the porous scaffold. Additionally, porous PHBV substrate acts as a good substitute carrier for tissue engineering of the ocular surface and possesses the capacity to replace other biological membranes as a substrate for LSC expansion. 152
Polyurethane stands out as among the most widely utilized synthetic polymers in the area of medicine. The mechanical properties and thermoplastic elastomer characteristics of these polymers render them appealing. Studies done recently have looked into the application of a new category of polyurethanes that demonstrate natural and biological degradation in regenerative medicine and drug delivery systems.153,154
Transforming corneal fibroblasts to a keratocyte characteristic in a three-dimensional structure is helpful for aligned fibrous formations. Alignment of cultured human corneal stromal stem cells (hCSSCs) induced by electrospinning resulted in aligned PEUU mats, which created a 7–9 μm thick collagen matrix on the substrate. Following the arrangement of collagen on the matrix, the PEU layer systematically detaches over time. The collagen fibers within this matrix demonstrated characteristic interfibrillar spacing and consistent width; they also showed a parallel alignment similar to that of the natural stroma.155,156
Natural and synthetic nanofiber for corneal tissue engineering
Several hybrid polymers and their application in corneal tissue engineering with electrospinning methods.
To identify the most ideal and appropriate scaffold for ocular tissue engineering, Arabpour et al. developed and created triple-layer electrospun nanofibers of poly(D, L-lactide-co-glycolide) (PLGA, 50:50) and aligned type I collagen nanofibers. The scaffold’s center layer was electrospun with aligned type I collagen nanofibers, while its inner and outer layers were made of PLGA nanofibers. To improve the scaffold’s mechanical properties and biocompatibility, PLGA and collagen were incorporated. PLGA (50:50) nanofibers were utilized as a scaffold for corneal endothelial and epithelial cells, while aligned type I collagen nanofibers were electrospun in the intermediate layer to act as a platform for corneal stroma. Collagen fibers that were aligned were utilized to enhance the mechanical characteristics. In consequence of their alignment and small size, aligned collagen fibrils have greater mechanical characteristics than the random form with adequate stromal transparency, as established by previous studies. 175 Under cell culture conditions, the shrinking of electrospun PLGA is an undesired characteristic.
Results demonstrated that the use of cross-linked scaffolds resulted in reduced scaffold shrinkage and a more gradual pace of degradation. The fibers at the nanoscale were in favorable form, according to the SEM assessment. Additionally, regarding both non-cross-linked and cross-linked materials, the in vitro examination showed enhanced proliferation and cell adhesion in the existence of endometrial stem cells of humans. According to this work, 169 it may be possible to create biodegradable electrospun nanofibers for applications involving ocular tissue engineering.
Another investigation used an electrospinning approach to produce a polycaprolactone (PCL)/silk fibroin (SF) hybrid scaffold in various ratios (70:30, 60:40, and 50:50). For ocular tissue engineering, SF provides requisite cell adhesion, biocompatibility, and optical transparency, while PCL gives the mechanical strength needed (that has beneficial strength characteristics for surgical stitches). The findings show that adding SF resulted in scaffolds with an additional consistent structure that is aligned. 176 The mechanical characteristics of hybrid electrospun scaffolds are directly affected by a number of things, such as the physical properties and interactions of the components, as well as the size of the fibers. 177 The ultimate tensile strength of corneal stromal tissue in the natural state is around 3–5, while the modulus of the young of it ranges from 0.3 to 7 MPa.178,179 For corneal applications, both nonaligned and aligned PCL-SF (50:50 and 60:40) fibers have a high tensile strength and Young’s modulus within an acceptable range. For corneal stromal engineering, pure PCL’s tensile strength is inadequate. The statistics show that the pure PCL had the least light transmittance out of every sample. It’s clear that the fiber orientation and the incorporation of SF into the PCL scaffold have an impact on the light transmittance of scaffolds. Therefore, it was shown that the optimum light transmission properties for corneal tissue engineering are found in aligned PCL-SF scaffolds (60:40 and 50:50). Notably, compared to the other scaffolds, the aligned PCL-SF scaffolds (60:40 and 50:50) showed greater levels of hydrophilic nature, transparency, in vitro deterioration pace, and water absorption.
HSKCs (human stromal keratocyte cells) are adhered to and proliferate on both non-aligned and aligned PCL-SF scaffolds, according to the cell compatibility data; however, the alignment of the structure has a direct and beneficial impact on the arrangement and gathering of cells. According to the MTT results, the scaffolds’ cell viability increases significantly and progressively when the SF ratio increases in comparison to the pure PCL scaffold. Improved cell viability is a consequence of SF’s hydrophilic characteristics, which greatly increase the adherence and proliferation of the cells. 180 However, at every time point, the alignment also is a crucial part of the viability and growth of hSKCs. The results show that, in comparison to the non-aligned PCL-SF (50:50 and 60:40) scaffolds, the aligned scaffolds planted with the human keratocyte cells show significantly increased proliferation (p < 0.05).
Nanofibers that mirror the extracellular matrix (ECM) are getting increasingly favored as suitable scaffolds for drug delivery and tissue engineering.173,181,182
In a study, polyvinyl alcohol (PVA) and hydroxyethyl cellulose (HEC) were used to generate nanofibers, which were then cross-linked with graphite and nano-hydroxyapatite conjugated with glutaraldehyde. In scaffolds for corneal tissue creation, two bioactive substances that have been utilized to enhance cell adhesion are graphite (GR) and nanohydroxyapatite (nHA). 173 A clear PVA was surrounded by varied quantities of nHA on the scaffolds containing GR. The final products have undergone a comprehensive evaluation employing different methods to establish their suitability for artificial cornea applications. HEC is a polymer characterized by its hydrophilic and biocompatible properties, making it appropriate for usage in tissue engineering and as an ingredient in eye drops designed to alleviate severe dry eye conditions. 183 Nonetheless, HEC is not an ideal polymer for the manufacture of microfiber scaffolds because of its inadequate tensile strength and the requirement for electrospinning. 184 As a result, HEC and polymers such as PVA have been combined. 185
PVA is a suitable polymer for ocular tissue engineering 186 owing to its high-water content and great elastic modulus, 187 as well as its excellent biocompatibility. 188 Incorporating nHA into polymers at higher concentrations can lead to the dissolution of nHA, resulting in the formation of the non-bioactive compound Ca-Na6(PO4). 189 Consequently, it has been advised to utilize low nHA concentrations for scaffolds. 190
The water content of the translucent PVA core was approximately 79.5%, closely resembling that of the average human cornea, which is around 78%. 191 With an increase in nHA quantity, there was a corresponding decrease in the pore diameters of the scaffolds, which likely accounts for the observed decrease in water content. For every sample, the water contact angle was below ninety degrees, suggesting that the structures exhibit hydrophilic properties. 192 For the polymers to endure suturing during implantation, scaffolds intended for artificial corneas need to exhibit significant tensile strength. Recent findings suggest that scaffold nanofibers employed in artificial corneas exhibit a greatest tensile strength of 6 MPa, in contrast to the average tensile strength of human corneas, which is around 3.5 MPa.102,193
Every scaffold nanofiber had a tensile strength of more than 7 MPa. Additionally, scaffold nanofibers with the least quantity of nHA usually didn’t break easily, as shown by the enlarged graph, indicating that the nanofibers’ flexibility was maintained. Furthermore, the composite nanofibers’ tensile strength was enhanced with an increase in nHA content. It was found that the scaffolds caused no harmful impacts on human corneal epithelial cells. Two distinct cell lines, the immortal HCE cell line (human corneal epithelial) and L929 mouse fibroblasts, were used to determine cell adherence on the scaffolds’ surface. Not many cells adhered to the PVA hydrogel. Proteins don’t stick to PVA hydrogels very well, which makes it hard for cells to bind to them. Even if they are biocompatible and hydrophilic, this is still the case. 194 This is beneficial for an artificial cornea because it preserves transparency optimally when there is little to no cell attachment to the core. Because graphite can absorb proteins, applying graphite to scaffold structures may increase L929 fibroblast adhesion to polymers. 195
Higher nHA concentrations resulted in fewer cells adhering to the scaffolds, suggesting that expanding the nHA content might cover the GR surface and reduce protein absorption. Smaller pore sizes in the polymers caused by an increase in nHA may also lead to a decrease in the cells’ number adhering to surfaces.196,197 The sample containing 1.66% w/w of nHA demonstrated the greatest cell adhesion, or the overall quantity of cells that were attached to the scaffolds. The diameter of HCE was decreased via raising the scaffolds’ nHA content. L929 cells did not experience such a strong change. Furthermore, the scaffold twisted somewhat because of the high concentration of nHA; hence, it was deemed inappropriate to utilize for further in vivo studies.
The corneal stroma can be described as thick tissue that makes up nearly 90% of the cornea’s thickness among these layers. Several materials have been investigated for stromal cell regeneration and possible transplantation. 198 Particularly, stromal cell attachment and proliferation are facilitated by collagen-based materials, even though their tensile strength is often lower than that of the human cornea. 199 Additionally, functional sequences like arginine-glycine-aspartic acid (RGD) that promote cell adherence may be present in gelatin, one of the collagen derivatives. 200 Alteration of chemicals with different functional groups, such as acyl azide, 201 aldehyde groups, 202 and carbodiimides, 203 has been performed to enhance the gelatin’s physicochemical properties.
Gelatin methacryloyl (GelMA) has recently become known as an encouraging hydrogel for tissue engineering utilizations 200 due to its adjustable physical properties and degradation. 204 Bektas et al.’s investigation on GelMA hydrogel’s applicability for corneal stroma engineering205,206 noted that the hydrogel produced high cell proliferation, stromal collagen, and proteoglycan production, as well as excellent transparency. Although GelMA has many useful qualities for a vast array of applications, it also has a number of disadvantages, including low mechanical strength and a quick rate of deterioration, which may require improvement based on the application. 205
In an additional study, they produced a hybrid scaffold with mechanical characteristics and increased transparency that might replace the corneal stroma. The scaffold was made from various ratios of silk nanofibers (SNF) to gelatin methacryloyl (GelMA). The toughness and tensile strength are notably enhanced through boosting the ratio of surface-to-volume, which is the outcome of SNF formation. 207 Furthermore, in comparison to raw silk fibroin, the existence of nanoscale-thinner silk strands may considerably improve the final film’s transparency and optical clarity. 208
According to the results, a desirable 30/70 SNF/GelMA ratio exhibits high mechanical characteristics that are similar to the native corneal stroma, hydrophilicity, and great transparency, having more than 85% transparency to light in the wet condition. This hybrid membrane has the following characteristics: toughness (0.46 ± 0.04 MPa), tensile strength of 3.8 ± 1 MPa, elastic modulus of 36.2 ± 7 kPa, and the capacity to absorb water as much as 138 ± 27% after 10 days (72 ± 1% in PBS, 62 ± 2% in synthetic tear solution) without exhibiting mineralization. 209
Corneal neovascularization (NV) is a medical disorder that leads to blood vessels proliferating too much from the stroma to the limbal zone. This disorder makes eyesight less clear over time. This syndrome is linked to inflammation, which can happen in conditions like atopic conjunctivitis and corneal graft rejection; trauma from things like chemical burns; infections from viruses, bacteria, or fungi; degenerative diseases; developmental disorders that are present at birth, like limbal stem cell deficit; and other diseases.210,211
Controlling corneal NV requires the utilization of anti-vascular endothelial growth factor (anti-VEGF), a medicinal medication that blocks the function of VEGF. 212 Known as intravitreal drug administration, the anti-VEGF is typically injected straight into the vitreous (posterior) chamber of the eye. Regrettably, the administration of drugs in this manner may be associated with several severe adverse effects, such as systemic and infectious endophthalmitis, rhegmatogenous retinal detachment, ocular hemorrhage, intraocular inflammation, and an increase in intraocular pressure. 213 According to reports, the anti-VEGF drug delivery method must meet the requirements listed here: biocompatibility, transparency, sufficient concentration, bioactivity, and prolonged and targeted delivery over a month. 214 In order to avoid abnormally high ocular vascularization, VEGF-blocking drugs are integrated into engineered biomaterials to enhance their performance and sustained target release. Studies that have been recently reported on the creation of fibrous scaffolds electrospun primarily use VEGF or, in a small number of cases, anti-VEGF chemicals, usually for tissue engineering goals.
In this work, an anti-VEGF substance was added to electrospun PCL by simple physical adsorption. The physicochemical characteristics and final function of anti-VEGF/PCL scaffolds in supporting limbal stem cells (LSCs) for corneal tissue engineering were evaluated. The anti-VEGF/PCL electrospun scaffold has a notably elevated modulus of elasticity. The findings indicate that the scaffolds’ flexibility is directly impacted by the biological component’s inclusion.
At both stresses of 5 and 10%, the anti-VEGF completely reduced the hydrophobicity of PCL and almost tripled its Young’s modulus, which improved the material’s tensile and wetting characteristics. The incorporation of the anti-VEGF leads to a notable rise in the storage modulus, indicating that the biological component’s strengthening impact has enhanced the scaffold’s mechanical behavior. The findings show that the anti-VEGF particles are positioned in the PCL’s amorphous phase and that their mobility has decreased. The results additionally confirmed the greater biocompatibility of anti-VEGF/PCL compared to a single PCL, which was discovered to be more beneficial to LSC attachment, differentiation, and growth as seen by the SEM, as well as the CK3 (a corneal epithelial cell differentiation) and p63 (presence of stem cells) markers following cell staining. The findings will aid in the development of electrospun scaffolds aimed at preventing angiogenesis during the LSC ocular tissue building process, facilitating long-term anti-VEGF administration. The upcoming investigations will focus on assessing the ongoing bioactivity of the biological material, gathering data regarding its release rate, and conducting a quantitative analysis of cell proliferation via the identification of CK3- and p63-positive stem cells or cells that are differentiated within the corneal epithelium. In the same way, certain limitations should be acknowledged and addressed. 27
The ailment known as limbal stem cell deficiency (LSCD) affects the cornea and is characterized by damaged or dysfunctional limbal epithelial stem cells (LESCs). Limbal stem cells are essential for corneal epithelial renewal, so LSCD can lead to corneal neovascularization, chronic epithelial defects, reduced vision, and pain. 215 The state described as LSCD (limbal stem cell deficiency) affects the cornea and is characterized by damaged or dysfunctional limbal epithelial stem cells (LESCs). Because for the corneal epithelium to regenerate, limbal stem cells are essential, LSCD can cause chronic epithelial defects, corneal neovascularization, reduced vision, and pain. 216
When it comes to ocular surface problems, amniotic membrane (AM) is the most frequently utilized and renowned membrane for cellular regeneration. 217 AM treatment carries a substantial risk of viral transmission, despite its unique ability to induce cell proliferation and epithelialization.216,218
Results about how the PCL/gel mix affects various cell types are debatable. According to some research, combining PCL with gel might improve cell adhesion.219,220 Other research also suggests that gel might not significantly change the PCL’s biological characteristics. 221
This study looked at how nanofibrous polycaprolactone (PCL) and PCL/gelatin (PCL/gel) affected limbal epithelial stem cells (LESC) and how well they transplanted in an animal model of alkaline damage. PCL and PCL/gel were evaluated with regard to LESC proliferation and adhesion, biocompatibility with the ocular, and ease of transfer after surgery. The electrospinning method produced PCL and PCL/gel with mass ratios of 50:50 and 70:30.
According to this study, PCL was better for LESC adhesion, stimulation of proliferation, and epithelial morphology than PCL/gel. Superior to PCL/gel, PCL may also be able to preserve the viability and morphology of LESCs. The finding may be the result of the differences in PCL and PCL/gel scaffold morphology. The broad range of sizes and irregularities of the fibers in PCL/gel composites might affect the pore diameter of PCL/gel relative to PCL. According to previous studies, various scaffold architectural characteristics can promote various cell adhesion and proliferation.222,223
The larger fibers will provide broader pore interformations, which will aid in cell adhesion and further penetration in the inner structure, according to Mijovic et al. 224 Therefore, the PCL fiber’s bigger diameter than that of the PCL/gel mixture may be advantageous for LESC adhesion and proliferation. The inability to blend PCL with gel to enhance PCL surface characteristics in LESC culture highlights PCL’s aptitude for limbal cell proliferation and adhesion in contrast to PCL/gel. Histopathologic examination of corneal sections from animals that had undergone transplantation revealed that whereas epithelial regeneration was nearly identical in the PCL and PCL/gel groups, there was a notable decrease in inflammation and vascularization in the PCL group. The histopathologic analysis of corneas post-surgery, alongside the ease of transfer during the procedure, offers compelling evidence supporting the effectiveness of PCL when contrasted with PCL/gel blends and amniotic membrane. 225
Female placenta tissue and human amniotic membranes (HAM) are currently the wound dressings’ highest standard for following ocular surgery. Their well-known beneficial characteristics include improving re-epithelization and having antibacterial and anti-inflammatory properties. 226 Usually, corneal ulceration or persistent epithelial abnormalities need suturing of the tissue in the patient’s eye. 227 Similar to the overwhelming number of allogeneic tissues utilized in tissue engineering, there are challenges with quality differences, a lack of donors, and possible infections. 228 Artificial wound dressings are the focus of study to solve these drawbacks. Electrospun nanofibrous scaffolds seem like a good approach, as they combine the qualities of permeability and high-specific-surface scaffolds, the latter of which is dependent on the fiber diameter. Numerous methods for modifying nanofibrous scaffolds have been written about in the literature, such as, 229 where, for better ocular tissue regeneration after surgery, scaffolds made by electrospinning with fiber diameters of 549 nm, 167 nm, 113 nm, and 35 nm were generated and coated using the method known as layer-by-layer (LbL) using heparin or hyaluronic acid. In contrast to nanoparticles coated using layer-by-layer (LbL) techniques for drug administration (e.g., Ref. 230), our approach included the direct immobilization of medicines onto the nanofiber surface. Using the application-oriented suture retention test (SRT), this work examines how fiber diameter affects medication loading and release kinetics and mechanical characteristics to further create customized nanofibrous scaffolds for the healing of corneal wounds.
Although a scaffold’s specific surface increases as fiber diameter decreases, there may be a threshold beyond which the scaffold’s modification by the LbL-coating technique is no longer effective. The best-performing scaffolds are PCL scaffolds, which have a 113 nm mean diameter, an increased capacity for drug loading, and a strong resistance to suture pull-out. 231
To see well, the cornea must be clear. The five main layers that make up the cornea all work together to keep it functioning well. It is around 550 μm thick. A highly organized monolayer of human corneal endothelial cells (HCEC) is formed on top of the Descemet’s membrane. Individual cells are approximately 5 μm thick and 18–20 μm wide. The endothelium establishes a diffusion barrier to the surrounding aqueous humor to keep the intraocular pressure of the anterior chamber under control. 232
Here, the pump function of the corneal endothelium (aquaporin 1 water channels and Na+/K+-ATPase) simultaneously balances the leakage of aqueous humor into the stroma, removing excessive stromal fluid and maintaining transparency. The density of endothelial cells (ECD) varies with age. However, there is an acceptable level of 500–600 cells per
A human corneal endothelium-containing artificial biomimetic transplant could reduce reliance on corneas from human donors, enabling more patients to access this vision-restoring procedure. Four types of scaffolds made of electrospun nanofibers constructed from polycaprolactone were compared in a study to cultivate corneal endothelial cells. Endothelial cells in the human cornea (HCEC-B4G12) were used to tissue-engineer PCL/collagen, PCL, PCL/chitosan, and PCL/gelatin scaffolds.174,236 Regarding their possible use as artificial posterior lamellar grafts, each scaffold was examined. Similar to the Descemet’s membrane, their very permeable fibrous network creates a solid but permeable scaffold. 237
Na+/K+-ATPase and ZO-1 antibody staining showed that cell functions were intact. A varied blend morphology might be revealed by showing that blending led to a decreased contact angle. By using live/dead staining, scaffold cytocompatibility could be checked for every group. The collagen and gelatin blended matrices showed notably higher cell viability, with 97 ± 3% and 98 ± 2% viable cells, independently. The scaffolds’ surface attaching the HCECs is visible on TEM images. The advantages of combined PCL nanofibrous scaffolds for endothelial keratoplasty of the cornea are emphasized in this work. A few hundred nanometer-diameter fibers make up nanofibrous scaffolds when PCL is blended with collagen, gelatin, or chitosan. For application in lamellar keratoplasty, PCL-GEL and PCL-COL solutions improve characteristics of nanofibrous scaffolds that are electrospun. Comparing these mixtures to PCL and PCL-chitosan scaffolds, more cells survive. While endothelial cells were visible by antibody labeling, no cytotoxic risk could be seen in any of the examined samples. Therefore, PCL-blend and PCL electrospun scaffolds appear to be viable alternatives to posterior lamellar keratoplasty.
Achieving structural mimicry through fiber alignment and porosity
A fundamental approach to attaining structural mimicry in engineered scaffolds involves the precise alignment of fibrous components, which significantly affects cell orientation and mechanical anisotropy. Aligned fibers can mimic the directional signals present in natural tissues such as muscle, tendon, and nerve. This alignment facilitates cellular elongation, extracellular matrix deposition, and the comprehensive organization of tissue. For instance, recent advancements in 3D printing and additive manufacturing have made it possible to control the orientation and geometry of strands with precision. This positioning allows for scaffolds to have hierarchical pores that encourage contact guidance and direct cell migration. In one study, researchers created a grid-in-grid polycaprolactone (PCL) scaffold using precision extruding deposition, which provided human mesenchymal stem cells (hMSCs) with alignment cues. 238 This experiment demonstrated that incorporating alignment at different scales can significantly influence how cells organize themselves. 239
Furthermore, adding a gradient in fiber orientation that goes from aligned to random areas has shown that it is better at replicating the gradual changes seen in native tissue structures. This technique enhances functional integration at the interfaces. Along with orientation, changing the pore structure and how they connect to each other is also important for achieving structural mimicry. The porosity of a scaffold affects how mass moves, how nutrients diffuse, and how well it can bend, all of which are important for how cells behave and how tissues mature. Reviews of the literature emphasize that scaffolds with interconnected porosity and optimized pore sizes—typically ranging from 50 to 300 µm for bone-like tissues—are essential for promoting vascularization and deep cellular infiltration. 240 Additionally, the interplay between fiber alignment and pore geometry can be effectively utilized: aligned fiber packing can create anisotropic channels, while larger macropores facilitate bulk transport. Take biomimetic hydrogels, for example. They’ve been crafted to align nanofibrils in a way that creates a flow-induced structure, allowing for directional ordering and the right amount of porosity to facilitate transport. 241 Scaffold designs can copy the complexity and function of natural tissues by using techniques like managing fiber alignment and making hierarchical porosity. This method works well to link synthetic materials to their biological counterparts.
Characterization of engineered corneal scaffolds
A comprehensive characterization of engineered corneal scaffolds is essential to validate their structural, mechanical, optical, and physicochemical compatibility with native corneal tissue. The accuracy of these constructs in replicating the cornea’s hierarchical structure influences transparency, mechanical strength, and their capacity to facilitate cellular adhesion, proliferation, and phenotype preservation.
242
A thorough assessment is necessary, including morphological analysis (SEM, TEM), mechanical testing (tensile strength, Young’s modulus), evaluation of optical properties, and studies of in vitro degradation and swelling. This multiparametric characterization reveals substantial correlations among fabrication parameters, microstructural organization, and functional outcomes, thereby reducing translational risk and facilitating the optimization of scaffold design for clinical applications in corneal regeneration (Figure 5). Comprehensive characterization of engineered corneal scaffolds. A multi-parametric assessment is essential to evaluate the suitability of scaffolds for corneal tissue engineering. The characterization encompasses four key areas: morphological analysis, mechanical testing, optical property, and in vitro degradation and swelling assessment.
Morphological analysis (SEM, TEM)
Scanning electron microscopy (SEM) ought to be employed as the principal method for recording the surface and mesoscale structure of corneal scaffolds. It is important to report fiber-diameter distributions, fiber alignment, surface imperfections (like beading), and pore interconnectivity in full, rather than just using single-value summaries. The quantification obtained via SEM facilitates direct comparisons with previous studies on corneal scaffolds, associating aligned or lamellar microarchitectures with enhanced optical transmission and anisotropic mechanical properties. Recent investigations into electrospun and 3D-fabricated corneal constructs have utilized SEM to illustrate lamellar alignment and the absence of bead formation in nanofibers, correlating with improved transparency and cellular coverage. 131
In addition, transmission electron microscopy (TEM) works well with SEM because it shows intrafiber and ultrastructural features that have a big effect on optical properties and bioactivity. Transmission electron microscopy can distinguish between core-shell morphology in coaxial fibers, fibrillar packing, collagen-like banding, and the state of dispersion or aggregation of incorporated nanoparticles or drugs at a scale of 1–10 nm. Recent comparative studies demonstrate that TEM validation of uniform nanoparticle incorporation or fibrillar organization forecasts enhanced mechanical homogeneity and more reliable epithelial/endothelial cell monolayers on scaffolds. 243 This necessitates the existence of paired SEM data sets, including quantitative distributions, alignment indices, and porosity estimates, along with TEM data focusing on the ultrastructural organization and localization of nanoparticles. Morphometric data should then be analyzed in conjunction with optical and cellular results.
Mechanical testing (tensile strength, Young’s modulus)
Uniaxial tensile testing is usually used to make stress-strain curves, which are used to test the mechanical performance of engineered corneal scaffolds. This process yields important quantitative metrics, like ultimate tensile strength and strain at break, as well as elastic properties, like Young’s modulus, which comes from the first linear segment. These factors have a big impact on how well the surgery goes, how well the sutures hold, and how well the graft can handle intraocular forces without becoming too misshapen. It is important to report both tensile strength and the method for calculating Young’s modulus because the method and the sample’s properties have a big effect on the values that come out. The hydration level, sample shape, testing speed, and type of test (uniaxial, biaxial, or indentation) can all affect modulus estimates by a wide range of values. Comprehensive reviews suggest integrating standard uniaxial tensile tests with an exhaustive account of sample preparation (including thickness, hydration, and gauge length) and additional tests (such as burst or suture pull-out tests) to enable significant comparisons of scaffold data with native corneal benchmarks.244,245
Comparative experimental studies demonstrate the influence of the fabrication method on mechanical properties and the relationship between reported values and those of native tissue. Kong et al. created a compressed-collagen/laser-perforated electrospun hybrid that, when set up correctly, showed an ultimate tensile stress of about 3.42 ± 0.22 MPa, which is similar to what has been found for native corneal stroma. The research demonstrated that macro-perforation, alignment of electrospun fibers, and collagen compression can be adjusted to either enhance or diminish stiffness and strength as needed. Recent evaluations of polymer scaffolds for corneal applications demonstrate that softer hydrogel-based Descemet/Endothelium substrates must achieve a balance between reduced Young’s moduli, essential for compatibility with the fragile posterior lamella, and adequate handling strength. Thin supportive mats or controlled cross-linking techniques are often used to address this compromise. These comparative results suggest that authors should provide both tensile strength and the Young’s modulus obtained from the slope, along with comprehensive test conditions. Furthermore, the reasons for choosing materials, alignment, crosslinking, and perforation for the scaffold should be backed up by showing how the construct fits in with the native corneal ranges that have been reported in the literature.246,247
Optical property assessment
Optical transparency and light-scattering properties are critical functional parameters for engineered corneal scaffolds, as even minimal opacity can markedly affect visual acuity post-implantation. It is common to use spectrophotometric measurements of transmittance and absorbance in the visible spectrum (380–750 nm) to test optical properties. These measurements include the total and diffuse transmittance, as well as the haze and scattering indices. In an experimental study conducted by researchers, collagen scaffolds at a concentration of 10% were tested as a measure of optical property transparency. The transmittance of these scaffolds at different wavelengths of visible light (450, 500, 550, 600, 650, and 700 nm) was evaluated using UV/vis spectroscopy and directly compared to normal mouse corneas. The results indicated that, despite satisfactory apparent transparency in all samples, the scaffold with a 10% collagen concentration exhibited the greatest similarity to the natural cornea in terms of leveling. This study underscores a significant engineering dilemma: lower collagen concentrations enhance transparency, whereas higher concentrations (e.g., 20%) provide superior mechanical strength, which is crucial for suturing and surgical procedures. This finding confirms that simultaneously achieving high optical clarity and sufficient mechanical strength remains a major obstacle in the development of corneal scaffolds. 248
Photographic-based optical assessment methods, along with spectrophotometry, provide a direct, image-based depiction of transparency and blurring, making them suitable for swift evaluations. Gonzalez-Andrades et al. devised a photographic-based method (PBM) that involves capturing a standardized stripe pattern from scaffold samples. They figured out a “transparency ratio” (TR) and a “blurring index” (BI). They discovered a robust correlation between TR (approximately 80.3 ± 2.8%) and the gold-standard inverse adding-doubling (IAD) measurements of diffuse transmittance across wavelengths (ρ > 0.6). Researchers in scaffold development can determine the optical purity of high spectral transmittance by contrasting these two methodologies. 249 Then they can decide if the best way to optimize is to reduce scattering (by aligning fibers, matching the refractive index, or separating the micro-phase) while also increasing raw throughput.
In vitro degradation and swelling studies
In vitro degradation and swelling assays are critical functional assessments for corneal scaffold candidates, forecasting alterations in thickness, porosity, and optical performance in the initial post-implantation phase. Hydrogels and protein-based membranes generally undergo degradation through enzymatic cleavage, involving collagenases and proteases, alongside hydrolytic processes in buffered saline. When looking at how well a scaffold can support cell engraftment without causing long-term inflammation, it’s important to identify the right balance between network stability and controlled mass loss. After 14 days in PBS, a gelatin electrospun nanofiber membrane made to replace Descemet’s membrane showed a thickness reduction of about 88.6% and changes in permeability. This example shows that quick degradation can make it easier to move donor cells quickly, but it could also hurt the structure if it doesn’t happen at the same time as the biological timeline. The kinetic results are significantly influenced by factors such as crosslinking chemistry and density (physical vs covalent), polymer composition (natural vs synthetic), and scaffold microstructure (including fiber diameter and porosity). Comparative in vitro protocols must document mass loss over time in conjunction with additional metrics, such as thickness, permeability (e.g., FITC-dextran flux), and variations in mechanical stiffness throughout the incubation period.18,247
Swelling is a crucial process because small changes in how much water is absorbed can change the alignment of the refractive indices and the curvature of corneal implants, which can then change how clear and powerful they are. Recent comparative analyses and experimental studies highlight two principal considerations: (1) Dual-crosslinked hybrid hydrogels, which have both physical and photo- or thermally activated covalent crosslinks, break down more slowly and in a more controlled way than single-mode networks. This improves dimensional stability and optical clarity. (2) Electrospun proteinaceous membranes usually lose mass faster, but they also have better initial permeability and cell compatibility. You can change the amount and type of cross linker to get the desired in vitro residence time.250,251
A thorough characterization of engineered corneal scaffolds, encompassing morphological, mechanical, optical, and degradation assessments, creates a fundamental basis for forecasting in vitro performance and facilitating in vivo application. Morphological profiling through SEM and TEM confirms microstructural integrity and cell-interactive topographies. Mechanical testing checks the cornea’s elasticity and strength, which should be similar to the cornea. An optical assessment makes sure that things are clear and that light doesn’t scatter too much. In vitro degradation and swelling studies corroborate dimensional and compositional stability during the healing process. The interconnected evaluations show how processing variables affect structural integrity, transparency, and biological performance. This approach makes it possible to optimize scaffold design in a logical way. Corneal tissue-engineering strategies can only reach clinically significant levels of transparency, biomechanics, and biodegradability that meet the physiological needs of the human cornea through multi-parametric and comparative characterization.
Cell incorporation and interaction with scaffold
Tissue engineering techniques are utilized to create an engineered corneal substitute that replicates the architecture of natural tissue and improves visual function. 252 The scaffold that was made must help tissue cells grow, divide, and support each other. The fiber alignment of the scaffold affects how different corneal cells behave, how they look, how they stick to things, and how they grow. 253 Previous studies show that keratocytes have better interactions on aligned scaffolds, while corneal epithelial cells have better interactions on randomly aligned scaffolds. Moreover, fiber alignment affects cell proliferation. 254 A multilayer nanofiber scaffold composed of silk fibroin and collagen, augmented with aloe vera and epidermal growth factor (EGF), was engineered to promote the regeneration of corneal epithelial tissue. The biological tests showed that the scaffold had better cell adhesion, higher viability, and more potential for differentiation. This made it possible for corneal limbal stem cells to grow and change into epithelial cells without needing special differentiation media. The study stressed that choosing and optimizing the concentrations of polymers like silk fibroin, collagen, and aloe vera is crucial because they affect the scaffold’s physical and biological properties. Controlling the composition and concentration of polymers improved cell adhesion, interactions between cells and scaffolds, and the rate at which growth factors or drug layers were released. The results show that the scaffold that was made creates a good microenvironment for cells to attach, grow, and change into different types of cells. This attribute makes it a good candidate for corneal epithelial layer regeneration.
The triple-layer electrospun nanofiber scaffold, which had PLGA layers on the outside and inside and type I collagen in the middle, made human stem cells stick better and grow faster. In vitro studies demonstrated that the cells adhered proficiently to the scaffold surface and exhibited substantial growth. The cross-linking of the scaffold made it more hydrophilic and stronger, which made it easier for cells to interact with it. The findings indicate that this scaffold design fosters an optimal environment for cellular growth, proliferation, and functionality, highlighting its considerable potential for corneal tissue engineering. 253
Another study created electrospun nanofiber scaffolds with different microstructures, such as random and aligned fibers, and different topologies, to help the cornea heal. The in vitro results indicated that all samples had high cell viability and that the microstructure of the scaffolds had a big effect on how the fibroblast cytoskeleton was oriented and arranged. Aligned fibers directed cellular growth in a uniform direction, while random fibers led to a disorganized arrangement. This study demonstrated that modifications in scaffold microstructure can affect cellular behavior, underscoring the considerable potential of electrospun nanofibers to modulate corneal cell responses to the implanted substrate. 255
Nanoparticles for corneal delivery of drugs
In addition to facilitating targeted administration and regulated drug release, nanocarriers can increase the bio-distribution and bioavailability of medicinal compounds. Eye drops are typically cleared rapidly from the corneal epithelium, necessitating using ocular drops with high medication doses on a regular basis. Controlled medication release from nanoparticles that stick to the corneal layer might greatly lessen the systemic and locally adverse effects of corticosteroid treatment. This approach improves treatment effectiveness and enhances patient compliance. 256
Particulate carriers, such as nanoparticles less than 1 μm in size, have the ability to deliver drugs. Nanoparticles offer various benefits for ocular drug delivery, including higher drug stability and solubility, increased adhesion, adaptable surface properties, drug targeting, regulated release, modulation of drug characteristics, and improved drug penetration. The nanoparticles’ surface charge assumes a significant role in adhesion and penetration through the mucous membrane, with positively charged nanoparticles adhering to the negatively charged corneal epithelial mucosa. Developing a polymeric nanoparticle-based controlled-release delivery method for the cornea can enhance therapy efficiency and the patient’s compliance.
The distribution of drugs through the eyes may benefit from the utilization of polymeric nanoparticles, especially those made of biodegradable and biocompatible polymers. They provide enhanced drug stability, bioavailability, controlled release, and particular tissue targeting. Overcoming anatomical obstacles to topical and systemic treatment for inner eye drug delivery is a complex challenge, and nanoparticles of polymers offer a potential solution with tunable size and surface properties. Mucoadhesion, surface ligands, hydrophobicity, charge, and size, as well as the suspension media and the administration route, all influence the ability of nanoparticles to pass through ocular barriers and disperse in the eye. They have to be precisely crafted for certain target tissues and eye conditions.
Polymeric nanoparticles are subdivided into two types of nanostructures: nanocapsules (NCs) and nanospheres. While NCs have a vesicular structure with a polymer encircling a liquid (lipophilic or hydrophilic) core, nanospheres are matricial structures. In these systems, the medication may be adsorbed onto a particle surface, dissolved inside, or imprisoned. The best quality for efficient ocular delivery is maintaining prolonged optimal medication concentration in the ocular area, and topical nanosized delivery systems with mucoadhesive properties are considered ideal for this purpose.
It is possible to create polymeric nanoparticles through the spread of pre-made polymers or the polymerization of monomers. The choice of method considers the polymer’s and drug’s solubility in various solvents, cost, and safety. The method of solvent evaporation, involving the polymer’s dissolution in a solvent, emulsification, and subsequent solvent evaporation, is a widely used technique.
Naturally biomaterials-derived nanoparticles
Natural nanoparticles’ use in drug delivery methods for corneal disease is being studied. Since biodegradable nanocarriers have demonstrated sufficient capabilities for this purpose, they are among the most appealing and challenging techniques for recurrent corneal drug delivery. However, drugs may be able to stay in different areas of the cornea for a longer period by using these types of nanoparticles (Figure 6). Schematic illustration showing the preparation of nanoparticles from natural polymers such as chitosan, gelatin, collagen, and hyaluronic acid for corneal tissue engineering applications.
Chitosan nanoparticle (CSNP)
A polysaccharide called chitosan originates from chitin, which is present in crustaceans. Because of this material’s nontoxic biodegradability, antibacterial and anti-inflammatory qualities, and biocompatibility, scaffolds for various kinds of tissues have been constructed. 257 Chitosan has poor mechanical qualities and breaks down quickly; however, the rate of dissolution may be changed. 258 Chitosan nanoparticles are especially fascinating for these reasons: i) they are easy to make in mild conditions; ii) they are a group of uniform particles that can change their size and surface charge; iii) they are great at bringing together different active compounds, like proteins, peptides, and nucleic acids; and iv) they can easily add other molecules to the nanomatrix structure, such as glucomannan, poloxamers, cyclodextrins, alginate, and hyaluronic acid.259,260 Several studies demonstrate that chitosan’s molecular weight may have an impact on several important features, including mucoadhesion, 261 permeability, 262 and biocompatibility. 263 Even though this polysaccharide is hydrophilic, CSNP may be more suited for encapsulating hydrophilic and hydrophobic drugs, such as doxorubicin, 264 as well as macromolecules like peptides262,265 and genes.266,267 Furthermore, by modifying the chitosan structure logically or by adding additional biomaterials to the nanocarriers, it is possible to create nanocarriers with improved durability in the biological environment, bioadhesiveness, and targeting. For instance, Tahereh Tayebi et al. used chitosan nanoparticles for corneal endothelial tissue engineering. They developed a transparent biodegradable scaffold for the culture of corneal endothelial cells by combining CSNPs with chitosan/polycaprolactone (PCL) membranes. Based on its transparency and biocompatibility, they found that the scaffold was proper for application in corneal endothelial regeneration. 125 To improve the biocompatibility of artificial corneas, Haleh Bakhshandeh et al. studied the application of nanoparticles of chitosan-dextran that contain bioactive macromolecules from the amniotic membrane in humans. They discovered that this strengthened the anti-angiogenic characteristic of the artificial cornea by causing a prolonged release of thrombospondin-1 and other anti-angiogenic agents (such as heparin sulfate proteoglycan and endostatin). 268 Mohd Abul Kalam et al. designed chitosan nanoparticles coated with hyaluronic acid for topical ocular dexamethasone administration, and they described their findings. A study on nanoparticles showed that following 3 months of keeping at ambient temperature, no significant alterations were seen in the physicochemical properties, drug release, encapsulation, or particle size. 269
Since chitosan can only marginally encapsulate hydrophobic medicines, its hydrophilic property puts it at a disadvantage. Researchers began incorporating additional polymers or oligomers into chitosan-based nanoparticles to mitigate this issue and enhance loading, targeted delivery, controlled drug release, and decreased nanoparticle-bound toxicity. These polymers or oligomers could include hyaluronic acid, sodium alginate, cholesteryl 3-hemisuccinate, Carbopol®, dextran sulfate, sulfobutyl ether-cyclodextrin, or lecithin, particularly in ocular drug delivery systems.
Because of their abundance of anionic functional groups, such as carboxylate, sulfonate, or phosphate moieties, these secondary polymers or oligomers can engage in electrostatic interactions with the positively charged chitosan. Their usage as crosslinking agents is facilitated by these interactions, much in the way tripolyphosphate is typically employed in chitosan crosslinking. In the ocular pharma block, this type of crosslinking provides the nanoparticles strength and compaction, which in turn prevents the drug from being washed away on the ocular surface, improves penetrability, reduces the first burst release, and has high bioavailability.
For 24 to 72 h in vitro, the polyionic complex nanoparticles made by combining hybrid chitosan and sodium alginate demonstrated a sustained drug release for the corticosteroid betamethasone sodium phosphate and the antibiotic gatifloxacin. When compared to systems that were just based on chitosan or alginate, the hybrid system demonstrated a decrease in the first burst release for gatifloxacin.
Chitosan-alginate nanoparticles were shown to successfully permeate rabbit scleral tissue in the ex vivo permeability test, demonstrating their potential for ocular medication administration. Additionally, in vivo tests in rabbit eyes have shown that, depending on the formulation, the nanoparticles permitted therapeutic quantities of betamethasone sodium phosphate to be released continuously for 12–24 h, while the rapidly removed free drug solution vanished in only 2 h.
Zhu et al. 270 produced thiolated chitosan and assessed its suitability for ocular administration as thiolated chitosan-sodium alginate nanoparticles. The thiolated chitosan-sodium alginate nanoparticles were non-toxic to human corneal epithelial cells (HCE), according to the findings of their in vitro cytotoxicity investigation. In comparison to chitosan-sodium alginate nanoparticles, thiolated chitosan-sodium alginate nanoparticles had more FITC (model drug) transported into corneas, were smaller, more stable, and stickier. They also demonstrated increased intracellular absorption by HCE cells.
Alonso and colleagues looked at how well hyaluronic acid (HA)-modified chitosan (chitosan-HA) nanoparticles delivered genes to the conjunctiva and cornea.271,272 As the formulation’s hyaluronic acid (HA) content rose, the chitosan–HA nanoparticles’ zeta potential shifted from positive to negative values. By successfully transfecting up to 15% of immortalized epithelial cells of the human cornea and normal cells of the human conjunctiva, transfection tests demonstrated that these nanoparticles could efficiently carry genes while maintaining cell viability and exhibiting no damage. Researchers discovered that when chitosan-hyaluronic acid nanoparticles were used topically on rabbits’ eyes, the conjunctival tissue absorbed the particles far more efficiently than the corneal epithelium. According to confocal images, the hyaluronan receptor CD44 stimulated fluid endocytosis, which led to the chitosan-HA nanoparticles’ internalization. The conjunctival cells had a higher density in the apical and basolateral areas, but the cells of corneal epithelium had a uniform distribution of the nanoparticles.
To treat glaucoma, Vyas and colleagues 273 assessed how well these chitosan-HA nanoparticles delivered dorzolamide hydrochloride and timolol maleate to the eye. As anticipated, as compared to chitosan nanoparticles alone, the inclusion of HA in the nanoparticles demonstrated enhanced transcorneal drug penetration and ex vivo mucoadhesion through isolated caprine corneal tissue. In vitro burst release was demonstrated by both chitosan-HA and chitosan nanoparticles. Because timolol was molecularly disseminated inside the chitosan/chitosan-HA nanoparticles, the majority of the loaded timolol maleate emerged; however, because of its crystalline structure, just 20% of the filled dorzolamide hydrochloride was liberated. No visible signs of ocular irritation were observed in albino rabbits following administration of chitosan-HA nanoparticles loaded with timolol and dorzolamide hydrochloride. After 24 h of instillation, they considerably decreased intraocular pressure in the albino rabbits’ contralateral eyes but less in their partner eyes.
Following instillation, the chitosan-HA nanoparticles reduced intraocular pressure (IOP) more than the chitosan nanoparticles and the medication solutions, and they also reduced systemic absorption of the two medications, dorzolamide hydrochloride and timolol.
Through self-aggregation, Yuan X et al. 274 created amphiphilic mixtures of hydrophilic chitosan and hydrophobic cholesterol (CH), producing CH-modified chitosan (chitosan-CH) nanoparticles, and assessed their efficacy for corneal drug administration. The median zeta potential of the generated nanoparticles was around 44 mV, and their average size as particles was around 200 nm. After topical treatment, they demonstrated excellent dispersion across the rabbits’ precorneal region. Because of chitosan’s capacity for bioadhesion, 71.4% of the chitosan-CH nanoparticle solution was still firmly in place in the precorneal region 112 min after administration, even though some of the suspension was seen to leak into the lacrimal sac via the lacrimal duct. The chitosan-CH nanoparticles then remained at the conjunctiva and cornea, but because of the cornea’s strong barrier, they were hardly able to penetrate the iris/ciliary tissue and reach the posterior section of the eye. A simple dialysis technique was utilized to successfully encapsulate the hydrophobic medication cyclosporine A (CsA) in nanoparticles. The addition of cholesteryl hemisuccinate (CH) to the chitosan mixture significantly increased the drug loading capacity and the encapsulation efficiency when compared to chitosan nanoparticles alone. Compared to just 6.2% and 41.8% with chitosan alone, we saw improvements of 9% and 73%, respectively. Compared to the chitosan nanoparticles by themselves, which had a greater initial surge (60% released in 4 h vs 62% released in 15 min), the chitosan-CH nanoparticles demonstrated a persistent release of CsA for more than 48 h. The hydrophobic property of the cholesterol component was most likely the cause of the lower initial burst. Additionally, this research demonstrated that adding hydrophobic poly(lactic acid) to the nanoparticles of chitosan-CH might decrease rapamycin release by lowering the proportion of rapamycin released after 12 h from 85% to 50% and greatly increase the loading efficacy of rapamycin by almost four times. Additionally, during corneal transplants in New Zealand rabbits, the immunosuppressive impacts of rapamycin were improved by the chitosan-CH/PLA nanoparticles. When it related to the median duration of corneal allograft survival (27.2 ± 1.03 days vs 23.7 ± 3.20 days), the outcomes were either comparable to or marginally superior to those from the rapamycin suspension.
Alginate
Drug delivery, tissue engineering, and encapsulation of cells are some of the medical and biological uses for alginate, a naturally generated biopolymer produced from seaweed. 275 It is made up of chains of β-D-mannuronic acid (M) and α-L-guluronic acid (G). It delineates the physical characteristics of the material. 276 Upon dissolving sodium alginate powder and introducing a calcium source (e.g., calcium chloride), sodium ions are substituted by calcium ions, leading to the creation of a hydrogel. Due to alginate’s deficiency in cell attachment sites, it requires modification or amalgamation with other polymers for corneal utilization. For example, alginate and gelatin nanofibers have been combined to form a corneal stromal scaffold. 277 The alginate hydrogel’s mechanical qualities were improved, and its Young’s modulus approached that of the native cornea because of the insertion of nanofibers. Additionally, ocular epithelial cells cultivated in vitro have been supported by oxidized alginate. 278 The quantity of study projects that have utilized alginate for corneal engineering has been limited due to its stability and lack of binding sites. Chitosan-coated alginate nanoparticles (NPs) were utilized by Sogol Kianersi et al. as an eye drug delivery device. To achieve this goal and distribute the anti-inflammatory medication betamethasone sodium phosphate, alginate nanoparticles were synthesized for this investigation. Three methods were used to produce alginate nanoparticles: electrospray, emulsification, and a combination of these two processes. Of these, emulsification was selected as the best technique. The following stage consisted of coating the alginate nanoparticles with two cationic polymers, chitosan and gelatin, to enhance adhesion capabilities and control drug release. In order to deliver more drugs to in vitro HCE cells and the cornea in vivo, Xuan Zhu et al. synthesized thiolated chitosan and sodium alginate nanoparticles for corneal drug delivery. 279 This resulted in improved mucoadhesive features. To administer daptomycin to the cornea, J. R. Costa and colleagues employed chitosan-coated alginate nanoparticles. The daptomycin-loaded CS-ALG nanoparticles were shown to have a negative charge and a range of sizes from 380 nm to 420 nm, rendering them appropriate for ocular use. With declining alginate-daptomycin mass ratios, the encapsulation efficiency ranged from 79% to 92%. 280
Gelatin
Gelatin, a naturally occurring protein obtained from the hydrolyzing collagen process, has been utilized in numerous tissue engineering contexts, one of them being the cornea. 281 Gelatin is an appealing material due to multiple considerations, including its low immunogenicity, biocompatibility, and low cost. 282 However, unless chemically crosslinked or mixed with another material, gelatin doesn’t have heat stability 23 and degrades rapidly. 283 While various approaches have also been investigated, the most popular techniques for crosslinking gelatin include N-hydroxysuccinimide (NHS) or carbodiimide (EDC),112,284 or glutaraldehyde, despite the examination of other ways. 282 You may also utilize methacrylic anhydride (MA) to change the chemical structure of gelatin to get GelMA, which can crosslink when it is exposed to UVA light. 285 The main advantage of employing GelMA is that, in contrast to most harmful chemical crosslinking procedures, the material can be mixed with the cells before crosslinking. GelMA has been used for corneal bioadhesives, endothelial sheets, and stromal scaffolds.205,286,287
Since collagen is the main component of corneal stroma, gelatin nanoparticles (GPs) were chosen for local administration because of their unique attributes, such as biodegradability and biocompatibility, 288 and because they have been utilized for ophthalmic purposes. 289 Numerous researchers have investigated the utilization of GPs for medication and gene delivery.290–293 Few studies have looked at the use of GPs for ocular and corneal administration. Vandervoort investigated GPs-encapsulated hydrocortisone or pilocarpine for topical ocular delivery. 294 Vandervoot didn’t perform in vivo or in vitro testing; instead, they described the various types of GPs and declared the medication release rates from these GPs. When GPs loaded with plasmid DNA were administered in vivo, the MUC5AC expression level in the conjunctiva was significantly greater than in the control group without treatment. Additionally, plasmid DNA in its naked form enclosed in GPs showed advantages for the delivery of genes to the eyes. 295 These findings indicate that GPs can serve as efficient delivery systems for topical drugs to the eyes. To distribute drugs to the surface of the ocular, Ching-Li Tseng et al. prepared GPs using a two-step desolvation method. They characterized GPs as cationic colloidal transporters that were effectively adsorbed onto the negatively charged cornea with no irritation to the eyes of rabbits and may be preserved in the cornea for an extended period. Consequently, GPs (+) have a lot of potential for utilization as ocular drug delivery vehicles. 296
Hyaluronic acid
Hyaluronic acid, often referred to as hyaluronan, is a kind of nonsulfated glycosaminoglycan (GAG). Hyaluronic acid is present in a variety of tissues. In the past, researchers have utilized it as a scaffold for corneal engineering, as well as for cartilage repairs and skin regeneration. 297 Koivusalo et al. showed that injured corneas could be repaired without the aid of sutures by seeding modified hydrogels based on hyaluronic acid with stem cells derived from adipose tissue. 298 Similarly, hyaluronic acid has been proposed as a useful endothelial cell carrier 299 and as an appropriate xeno-free substrate for growing ocular epithelial cells.300,301 The low to no immunogenicity, non-inflammatory responses, biodegradability, biocompatibility, and bioavailability of HA nanoparticles represent some of its many advantages. 302 Hyaluronic acid has been linked to lymphangiogenesis in the limbus, which may be a limitation on its use for corneal tissue regeneration even with some favorable results. 303 Additional research is required to comprehend this relationship fully. The Zein-HA NPs, according to Telma A. Jacinto et al., were synthesized using the FNP method and loaded with ciprofloxacin for ocular mucosa administration. The Zein-CPX-HA NPs, on the other hand, exhibited a hydrodynamic diameter of less than 200 nm and a polydispersity index of less than 0.3, making them suitable for ocular drug delivery. Moreover, the nanoparticles were effectively freeze-dried utilizing mannitol as a cryoprotectant, enabling their resuspension in water without altering their physical and chemical characteristics. 304 Mona M.A. Abdel-Mottaleb asserts that HA nanoparticles serve as an effective space-filling matrix to preserve the structural integrity of the anterior chamber during ocular surgical procedures. Moreover, researchers use HA solutions as an adjuvant for ocular tissue healing and to enhance the viscosity of eye drops. 302 Hyaluronic acid-chitosan nanoparticles, as documented by De la Fuente M and colleagues, were synthesized via a gentle ionotropic gelation method. Nanoparticles, which exist in sizes ranging from 100 to 235 nm, were tested for ocular gene delivery and showed a high transfection efficiency without negatively affecting cell viability. 305
Decellularized cornea
Decellularization of an organ is the procedure of eliminating individual cellular material and its detritus to create a scaffold without cells pertaining just to the ECM. The probability of graft rejection is decreased by reducing major histocompatibility complexes (MHC) through cell removal. The primary benefit of employing decellularized corneas is that the resultant scaffold is expected to possess the same biochemistry as the original tissue. Moreover, the corneal stroma’s perfect collagen arrangement may be preserved, which is challenging to imitate with alternative biomaterials. During the decellularization process, the scaffolds should stay sterile, though gamma irradiation terminal sterilization is frequently employed to guarantee sterility.303,306–308 A recent study has shown that gamma irradiation does not substantially alter the structure of the extracellular matrix (ECM). 309 Batch-to-batch variability is anticipated owing to donor variability, as is common with many materials. It is crucial to verify if the corneas have been adequately decellularized. Macrophage polarization towards an M1 phenotype has been seen both in vivo and in vitro when decellularization is insufficient. 310 Activation of B lymphocytes may also take place, along with the binding of immunoglobulin and protein complement to remaining cellular components. 311 Overall, the treatment with decellularized cornea enhanced mechanical characteristics, promoted the expression of several keratocyte markers, and increased collagen fibril density. 312 The majority of decellularization techniques rely on a combination of various methods. Physical techniques include freeze-thawing, agitation, 313 elevated hydrostatic pressure, 314 or supercritical carbon dioxide. 315 Chemical agents encompass detergents, including sodium dodecyl sulfate (SDS), 316 sodium deoxycholate (SDC), 317 Triton X-100, 318 or lauroyl glutamate 319 ; organic acids, including peracetic acid 320 and formic acid 321 ; basic compounds, including ammonium hydroxide 322 ; and hypertonic solutions, primarily 1.5 to 2 molar sodium chloride. 323 Biological techniques employed encompass widely utilized cell dissociation agents, including dispase II and trypsin 324 ; alternative catalytic enzymes, such as phospholipase A2 325 ; serum from humans 326 ; and nucleases, such as RNAses and DNAses. 327 Every one of these strategies exhibits advantages and drawbacks, which have been emphasized earlier. 328 The primary constraints of certain decellularization methods may encompass inadequate elimination of DNA and cells, depletion of ECM components, disturbance of the stromal matrix architecture, and the persistence of chemical agents inside the scaffold that may compromise its biocompatibility. Consequently, process optimization is necessary. Ghasem Yazdanpanah et al. proposes a bioactive nanoparticle from human corneal extracellular matrix (HC-ECM). They used decellularized cornea pieces that were then lyophilized and cryo-milled into microparticles (<230 µm particle size). The ECM microparticles were turned into nanoparticles by stirring in 5% acetic acid (5 mg/ml) followed by probe sonication, and the average size of HC-ECM nanoparticles progressively decreased with increased time of acetic acid treatment (1645.3 ± 373.5 nm, 843.5 ± 301.4 nm, and 390.9 ± 331.4 nm after 24, 96, and 168 h, respectively). However, the mean polydispersity index (PDI) increased, which indicates the reduction in uniformity of produced nanoparticles, and proliferation of HCECs was significantly improved after treatment with HC-ECM nanoparticles compared to controls. 329
Synthetic nanoparticle
Nanoparticles of poly (alkyl cyanoacrylate)
Nanoparticles of poly (alkyl cyanoacrylate) (PACA) originated in the beginning of the 1980s and have been thoroughly investigated for pharmacological transport to the brain and the eye. PACA nanoparticles have been generated using emulsion and interfacial polymerizations using monomers or through nanoprecipitation and emulsion-solvent evaporation utilizing presynthesized PACA polymer. The initial nanoparticles studied for the delivery of ophthalmic medications topically to the eyes were PACA nanoparticles because of the superior adhesive qualities of alkyl cyanoacrylates. 330
Poly (2-hexyl cyanoacrylate) nanoparticles exhibited a fourfold increase in concentration inside inflamed albino rabbit ocular tissues compared to tissues that were healthy. Hydrophobic pharmaceuticals, including acyclovir and pilocarpine, as well as hydrophilic compounds such as amikacin sulfate and betaxolol hydrochloride, were effectively encapsulated within PACA nanoparticles. Poly(butyl cyanoacrylate) PBCA nanoparticles made the myotic response to pilocarpine better in albino rabbits; made the amikacin sulfate levels in the cornea and aqueous humor higher when dextran 70,000 was present; and improved the absorption of positively charged betaxolol hydrochloride via decreasing the surface’s zeta potential, hence influencing the possible antiglaucoma efficacy of betaxolol hydrochloride, depending upon the quantity of the drug released. 331
Despite the discovery in the 1990s that PACA nanoparticles induce cell lysis and corneal damage, their investigation for ocular drug delivery has been infrequent, although enhanced ocular tolerance was noted in a 6-h tolerance assessment when PACA nanoparticles were coated with poly(ethylene glycol) (PEG) polymers. Investigators transitioned to alternative, new biocompatible polymers to create polymeric nanoparticles intended for ocular administration. 332
Polyester nanoparticles
Polyesters, including poly(ε-caprolactone), poly(lactide), and poly(lactide-co-glycoside) (PLGA), are synthetic polymers that exhibit biodegradability and favorable biocompatibility. These polymers have lately been actively employed in the fabrication of microparticles, nanoparticles, and implants for controlled release of drugs and delivery of drugs to specific sites. Nanoparticles constructed from poly(lactide), PLGA, and poly(ε-caprolactone) have been assessed for the purpose of delivering drugs to the eyes.
PLGA, PCL, and PLA nanoparticles, either drug-encapsulated or non-drug-encapsulated, have been produced utilizing solvent evaporation in oil-in-water (o/w) emulsions and solvent displacement (nanoprecipitation) methods. The resultant nanoparticles show particle sizes that range from one hundred to several hundred nanometers and possess a negative zeta potential. Drugs that are hydrophobic, such as cyclosporine A, indomethacin, sparfloxacin, flurbiprofen, and natamycin, and drugs that are hydrophilic, such as diclofenac sodium and brimonidine, were enclosed within these polyester nanoparticles. This paper indicates debates about the investigation of poly (lactide), PLGA, and poly (ε-caprolactone), along with their nanoparticles that come from them, focusing on their ability to cover up the eye irritation caused by the medicine, optimize pharmaceutical loading in formulations, elevate the duration of drug retention in the precorneal region, and improve pharmaceutical permeation via the cornea or the conjunctiva-sclera obstacle to access its inner anterior segment.
Polymeric micelles were created via the self-assembly of amphiphilic copolymers containing hydrophilic pendant chains of poly (ethylene glycol) modified by azide groups and poly (2-methyl-2-carboxytrimethylene carbonate-co-D, L-lactide) as the hydrophobic backbone. In order to target cornea epithelial cells via RGD receptors, the GRGDS peptide was coupled to the self-assembled micelles. The ability of such GRGDS-modified micelles to significantly inhibit corneal epithelial cell attachment to GRGDS-coated plates was demonstrated by an in vitro assessment of their binding affinity to rabbit corneal epithelial cells. The finding suggests that these micelles may facilitate the direct delivery of pharmaceuticals to the damaged eye.
Vega et al. evaluated the ex vivo permeability in PLGA nanoparticles made by nanoprecipitation via the cornea of New Zealand rabbits. 333 The outcomes revealed that the PLGA nanoparticles greatly improved flurbiprofen’s corneal penetration by about two times compared to the commercial Ocuflur™ eye drops and four times compared to free flurbiprofen PBS solution (pH 7.4). The corneas remained uninjured throughout the 6-h ex vivo corneal permeability testing, according to the corneal hydration study.
Similar enhancements in drug penetration were seen for PLGA nanoparticles containing sparfloxacin in ex vivo goat corneas. Additionally, an in vivo ocular retention investigation conducted on New Zealand rabbits utilizing scintigraphy showed that radiolabeled sparfloxacin-loaded PLGA nanoparticles exhibited a much slower clearance rate and prolonged retention time on the corneal surface compared to conventional sparfloxacin ophthalmic drops. This was demonstrated by the observation that following local administration, radioactivity was identified within the circulatory system (bladder and kidney) at 6 h with radiolabeled sparfloxacin ophthalmic drops and not with PLGA nanoparticles loaded with radiolabeled sparfloxacin; additionally, radioactive levels at the surface of the cornea within the initial 0.5 h rapidly diminished with radiolabeled sparfloxacin ophthalmic drops, whereas they remained relatively stable with PLGA nanoparticles loaded with radiolabeled sparfloxacin. PLGA nanoparticles exhibit non-mucoadhesive properties owing to their hydrophobic and negatively charged surfaces. Thus, the extended retention of the nanoparticles is likely due to their diminutive size (180–190 nm). 334
Besides the influence of PLGA nanoparticle size, the poly (vinyl alcohol) stabilizer was observed to enhance nanoparticle retention duration by augmenting the viscosity of the dispersion of nanoparticles, attributable to the hydrophilic characteristics of the poly (vinyl alcohol) polymer. PLGA and poly (lactide-co-glycolide-leucine) polymeric nanoparticle suspensions with sizes of about 125–190 nm and zeta potentials of about −25 mV demonstrated a biphasic release profile of the medication. There was an initial fast release (about 50% in the first 2 h), succeeded by a secondary slow-release phase that lasted up to fourteen hours. The particles did not irritate the cornea, conjunctiva, or iris for 24 h after being applied topically to rabbit eyes. 335
Local ophthalmic drug delivery has been investigated by Alonso and colleagues using PCL nanocapsules. The PCL nanocapsules were synthesized from lecithin, Miglitol 840, and PCL via the solvent displacement method. The PCL nanocapsules loaded with fluorescent dye, averaging 252 nm in size, improved the rhodamine 6G penetration into the corneal epithelial cells in New Zealand rabbits via endocytosis ex vivo. Following topical application to the cul-de-sac of fully conscious New Zealand rabbits, these nanocapsules were carefully internalized into the corneal epithelial cells compared to conjunctival cells. 336
PCL nanocapsules containing indomethacin exhibited a median particle size of 238 nm and a potential zeta of −39 mV. These nanocapsules were tolerated well by New Zealand rabbits and resulted in significant increases in concentrations of indomethacin in the cornea (approximately a 3.2-fold rise in AUC) and aqueous humor (approximately a 4.3-fold rise in AUC) compared to the over-the-counter ocular solution Indocollyre following topical administration into the right eye’s cul-de-sac in New Zealand rabbits. 337 Following the functionalization of PCL nanoparticles with poly-d-glucosamine, the resulting nanoparticles demonstrated an extended natamycin release for a maximum of 8 h in vitro and notably enhanced relative bioavailability, ranging from approximately 6.03 to 6.39 times greater than that of the over-the-counter natamycin solution (Natamet®).
Ibrahim et al. 338 administered brimonidine to nanoparticles composed of PLA (152 kDa weight of the molecules), PLGA 75:25 (66–107 kDa weight of the molecules), and PCL (14 kDa weight of the molecules), which exhibited a median size of the particles of 117–131 nm and a zeta potential ranging from −18 to −28.11 mV. The nanoparticles demonstrated an encapsulation capacity of 68–78% for brimonidine. The efficiency of encapsulation was observed to increase in the sequence of PLGA < PLA < PCL, correlating with the growing hydrophobicity of these polymers and the solid-state solubility of the brimonidine freebase, which is hydrophobic within the polymers. The rates of release in vitro for brimonidine derived from nanoparticles were observed to increase in the following order: PCL > PLGA > PLA. This trend is attributed to the decreasing weights of the polymers’ molecules utilized in the synthesis of nanoparticles. Ibrahim et al. incorporated brimonidine-loaded nanoparticles into methyl cellulose-based gels, demonstrating that the resultant brimonidine-nanoparticle-gel systems exhibited a significantly greater intraocular pressure (IOP) reductive impact compared to brimonidine-containing Alphagan P® ophthalmic solution (effective duration ranges from 15.2 to 23.2 h compared to 7 to 7.4 h) following application in BXD (boxed molecular dynamics) mice.
Composite nanoparticle
Synthetic and natural polymers can be combined to achieve improved functional properties. Synthetic polymers are utilized for their stable mechanical properties, while natural polymers are applied to improve cellular behavior. Biodegradable polymers, such as PCL, PLA, PEG, and PLGA, are widely studied for ophthalmic applications owing to their capacity to enhance the residence time of formulations on the precorneal surface.
Polymeric nanoparticles are promising carriers for ocular drug delivery. They have many benefits, such as being biodegradable, biocompatible, and non-toxic. They also help poorly permeable drugs get into cells better, keep drugs in cells and tissues longer, and release drugs more slowly. They possess the capacity to transform ocular drug delivery, overcoming traditional limitations and improving therapeutic outcomes. This section summarizes the most common composition of natural-synthetic polymeric nanoparticles for corneal treatment.
PCL-based nanoparticles
Polycaprolactone (PCL) is semi-crystalline, hydrophobic, and FDA-approved for medical applications in humans. It has garnered considerable interest as a drug delivery matrix due to its notable biocompatibility, controlled drug release, and biodegradability. PCL may be utilized either as a standalone polymer or in combination with other polymers. In addition to its cost-effectiveness and solubility in a broad range of solvents, PCL has demonstrated excellent controlled release and optimal drug loading capabilities, along with exceptional stability. PCL nanoparticles can penetrate the cornea and improve topical drug delivery. However, a major limitation for PCL-based nanoparticles applied to the eyes is the swift removal from the ocular surface, ascribed to their surfaces’ negative charge. To enhance the stability of PCL nanoparticles, surface coating or modification by a positively charged, mucoadhesive polymer is essential.
PCL nanoparticles, when combined with benzalkonium chloride, demonstrated enhanced distribution to the cornea relative to other PCL nanoparticle formulations, regardless of the presence of mucoadhesive coatings or different penetration enhancers. Conversely, PCL nanoparticles coated with PF68 demonstrated a considerably increased distribution to the iris, suggesting improved transcorneal diffusion, which was further enhanced by the presence of penetration enhancers. Penetration accelerators can augment the transcorneal diffusion of topically administered nanoparticles; however, negative consequences have been noted in the cornea and other ocular tissues, particularly with repeated applications. Additional testing is required to enhance the effectiveness of treatment and safety.
Salama et al.'s work 339 examines the synergistic benefits of nanotechnology and bioadhesive gel characteristics employed in the advancement of an ocular pharmaceutical delivery system aimed at addressing ocular inflammation. Nanoparticles encapsulating the antibiotic agent ofloxacin have been produced via the emulsion solvent evaporation method, employing a 23 full factorial design to assess the influence of formulation parameters, specifically the polymer’s (polycaprolactone) molecular weight, the amount of Kolliphor P188, and the existence of the charge inducer (chitosan hydrochloride), regarding the measured responses: particle size (PS), drug entrapment efficiency (EE%), polydispersity index (PDI), and zeta potential (ZP). The optimized LPCL-NP2 formulation, which had low molecular weight polycaprolactone, 500 mg of Kolliphor P188, 0.25% chitosan hydrochloride, and 50 mg of ofloxacin, had a spherical shape, an encapsulation efficiency (EE%) of 89.73 ± 0.04%, a particle size (PS) of 195.4 ± 13.17 nm, a polydispersity index (PDI) of 0.323 ± 0.01, and a zeta potential (ZP) of 55.4 ± 0.66 mV. The DSC analysis validated the drug’s amorphous characteristics. The optimized nanoparticle formulation was subsequently integrated into the subsequent ocular formulations: gel (LPCL-NP2-G4) and in situ forming gel (LPCL-NP2-ISG4).
The assessment of optimized ocular formulations’ penetration was conducted using confocal laser scanning microscopy. The investigation of antimicrobial properties examined three ocular formulations: LPCL-NP2 (ophthalmic drops), LPCL-NP2-ISG4, and LPCL-NP2-G4, alongside a commercial product, utilizing rabbits infected in their eyes with E. coli. The results indicated that rabbits given LPCL-NP2-ISG4 had a strong antibacterial effect and a big drop in bacterial growth. The effectiveness was shown by looking at eye biopsies from the rabbits compared to other groups. This paper describes a new formulation of ofloxacin-loaded nanoparticles made with polycaprolactone. The nanoparticles form a non-irritating, mucoadhesive ocular gel that is better at killing bacteria.
Shi et al. recently created a new block copolymer nanosuspension made up of chitosan (CS) and methoxy poly (ethylene glycol)-poly (ε-caprolactone) (MPEG-PCL). This system successfully encapsulates hydrophobic diclofenac (DIC) via self-assembly into cationic micelles. 340 The in vitro release study demonstrated a sustained release of 73% over 8 h. This release is affected by factors such as drug efficiency and diffusion, polymer degradation, and the interaction between the carrier and the drug. The drug’s release profile and pre-corneal penetration of the drug have been demonstrated. Burst release was observed in DIC/MPEG-PCL-CS; however, from a clinical perspective, during this initial release phase, the drug concentration rapidly attained the required level prior to the sustained release phase. In comparison to commercial eye drops, cornea penetration in DIC/MPEG-PCL-CS was 1.4 times higher. In vivo penetration tests indicated that the Nile red MPEG-PCL-CS nanosuspension had a higher fluorescence intensity than the Nile red aqueous solution. This suggests that it penetrated better. The ocular irritation test indicated that the polymer’s cationic properties caused temporary irritation that went away after 6 h. After 24 h of use, there was no more irritation. The maximum concentration of DIC in the aqueous humor for DIC/MPEG-PCL-CS, as indicated by the region shown by the aqueous humor concentration curve, is approximately 2.3 times greater than that of the marketing eye drop.
Shahab et al. 341 create chitosan-coated polycaprolactone nanoparticles loaded with dorzolamide (DRZ-PCL-CS-NPs) for enhanced ocular delivery. The nanoparticles were synthesized using a single-step emulsification method. The optimized DRZ-PCL-CS-NPs had a polydispersity index of 0.18 ± 0.04, a particle size of 192.38 ± 6.42 nm, an encapsulation efficiency of 72.48 ± 5.62%, and a zeta potential of +5.21 ± 1.24 mV. The independent and dependent response variables demonstrated a significant correlation, thereby affirming the validity of the optimized DRZ-PCL-CS-NPs. The DRZ release from CS-PCL-NPs exhibited biphasic activity, characterized by an initial burst release over 2 h, followed by a sustained release lasting up to 12 h during the study period. The corneal flux experiment indicated that penetration into goat cornea increased considerably. Compared to the control, DRZ-PCL-CS-NPs exhibited a 3.7-fold enhancement in mucoadhesive strength. The histological evaluation and HET-CAM investigation indicated that the DRZ-PCL-CS-NPs were non-irritating and harmless for ocular use. Consequently, it can be inferred that the optimized DRZ-PCL-CS-NPs are safe and possess the potential for effective ocular administration and enhanced therapeutic efficiency. Hashemi Nasra et al. 342 A contact lens loaded with nanoparticles was created to continuously release a hydrophobic drug, with the goal of improving the effectiveness of topical eye medication. We made crosslinked nanoparticles by using PCL, polyethylene glycol diacrylate (PEG-DA), and 2-hydroxyethyl methacrylate (HEMA) in a miniemulsion polymerization process that didn’t use surfactants. The lens material was synthesized using the photopolymerization of N-vinylpyrrolidone (NVP) and HEMA, employing PEG-DA as the crosslinking agent. The impact of nanoparticle incorporation on essential contact lens characteristics, including water content, transparency, modulus, and oxygen and ion permeabilities, was examined. Hydrogels and nanoparticles demonstrated significant vitality, signifying the lack of stimulatory and cytotoxicity effects. Drug release investigations demonstrated that the nanoparticle-embedded hydrogel released the drug over a duration of 12 days. This study’s results demonstrate that nanoparticle-loaded hydrogels could help with prolonged administration of loteprednol etabonate and maybe other pharmaceuticals.
Yenice et al. 247 assessed the concentrations of ocular tissues and fluids following the topical application of hyaluronic acid (HA)-coated PCL/BKC nanospheres and poly-ɛ-caprolactone (PCL)/benzalkonium chloride (BKC) nanospheres on healthy rabbit corneas. Nanospheres were made by nanoprecipitation and then cleaned up by gradient-rate centrifugation. We used one of three formulations to treat rabbit corneas with Cy A (0.1%): castor oil formulation (group 1), PCL/BKC nanosphere formulation (group 2), or PCL/BKC nanosphere formulation coated with HA (group 3). Tear samples were collected using Schirmer tear strips. The mean corneal Cy A concentrations measured at 0.5, 1, 2, 4, 8, and 24 h post-instillation of the formulations varied from 0.12 to 1.2 ng/mg tissue for group 1, 5.9 to 15.5 ng/mg tissue for group 2, and 11.4 to 23.0 ng/mg for group 3. The conjunctival Cy A levels in groups 2 and 3 did not show significant differences at any of the assessed time points. Nevertheless, the Cy A level of the castor oil formulation and the PCL/BKC nanosphere formulation differed significantly at 1 and 8 h (p < 0.05). At no time point where the average iris/ciliary body concentrations of the three formulations substantially different, with the exception of group 2’s levels being greater than those of groups 1 and 3 at 1 h (p < 0.05). The minimal ocular tear Cy A concentrations (16–114 ng/ml) were observed after the administration of HA-coated PCL/BKC nanoparticles (group 3) throughout the testing period. Cy A concentrations in the cornea could be 10 to 15 times higher with HA-coated PCL/BKC and Cy A-loaded PCL/BKC nanospheres compared to Cy A solution in castor oil. The combination of nanospheres and hyaluronic acid may significantly contribute to the efficient delivery of higher concentrations of cyclosporine A within the cornea.
To enhance the ocular permeability of dexamethasone (DEX), Alami-Milani et al. 343 investigate the feasibility of synthesizing micelles composed of polylactide-polycaprolactone-polyethylene glycol-polycaprolactone-polylactide (PLA-PCL-PEG-PCL-PLA). PLA-PCL-PEG-PCL-PLA copolymers were created by a ring-opening polymerization technique. DEX was infused with the synthesized copolymers. The permeability of the cornea was assessed with an ex vivo bovine model. The micelles demonstrated appropriate compatibility with L929 cells. The release profile exhibited an early burst release phase that was followed by a persistent release phase, the kinetics of which closely aligned with the Weibull distribution model. The micelles indicated superior corneal permeability relative to a commercially available DEX eye drop. The findings together suggested that the PLA-PCL-PEG-PCL-PLA micelles may serve as suitable options for the ocular administration of DEX and maybe other hydrophobic pharmaceuticals.
PLA-based nanoparticles
Polylactic acid (PLA), a polyester composed of lactic acid components, stands out as one of the most extensively researched synthetic polymers in different biomedical usages. These applications include, but are not limited to, ophthalmic implants, tissue engineering, and, particularly, drug systems for delivery. PLA is recognized for its biocompatibility and biodegradability under enzyme-activated or hydrolytic conditions, coupled with its mechanical flexibility. Formulations based on PLA have received approval from the United States Food and Drug Administration. Furthermore, the chemical and physical properties, as well as the structure of PLA, can be precisely regulated to cater to diverse requirements. This control is achieved through choosing the molecular weight, integration with additional materials, and specialized functionalization, enabling the attainment of tunable drug release rates. PLA nanoparticles exhibit promising potential for specific targeting and prolonged drug delivery.
In the realm of ocular drug delivery systems, PLA has been investigated as a potential drug delivery system. Studies have demonstrated that subconjunctival delivery of PLA nanoparticles at varying sizes produces unique therapeutic efficacies in a rat model of laser-induced neovascularization. Hydrophobically altered chitosan was synthesized using poly(lactic acid) (PLA) as a grafting agent. PLA nanoparticles, investigated as carriers for drug delivery, have exhibited favorable attributes, including prolonged drug release and safeguarding medicines from deterioration over a protracted duration.
Giannavola et al. have indicated that PLA nanoparticles loaded with acyclovir prolonged acyclovir release and were effectively tolerated by the rabbit’s ocular. which substantiates the potential of the PLA nanoparticulate framework for ophthalmic therapeutics and their delivery. 344
Nguyen et al. recommend using the influence of shell thickness in hollow poly(lactic acid) nanoparticles (HPLA NPs) for prolonged treatment of glaucoma. Formulations utilizing pilocarpine-loaded HPLA nanoparticles, with variable shell thicknesses ranging from 10 to 100 nm, demonstrated significant efficacy in vivo with rabbit eyes and in vitro with human lens epithelial cells. The thickness of the nanoparticle shells greatly influenced the release of pilocarpine. Coatings that have thicknesses ranging from 70 to 100 nm prolonged the drug release profiles, but they also complicated the drug loading process. Conversely, nanoparticles with ultrathin shells approximately 10 nm in width exhibited distinct and less favorable release patterns. A shell thickness of about 40 nm gave a balanced and steady release pattern, keeping therapeutic levels (about 10 µg/mL) for at least 8 weeks. In in vivo studies utilizing a rabbit model of glaucoma, it was demonstrated that a single administration of HPLA nanoparticles with approximately 40 nm shells, delivered directly into the eye, significantly lowered intraocular pressure for a duration of up to 56 days. This formulation saved the integrity of the corneal endothelial structure, kept the normal electrophysiological function of the retina, and attenuated the degeneration of the retina and optic nerve in eyes deteriorating due to glaucoma. The results demonstrate the worth of shell thickness in the design of nanoparticle-based, long-acting ocular drug delivery systems aimed at chronic eye diseases. 345
Nagarwal et al. create a poly (D, L-lactic acid) (PLA) nanocarrier for topical ocular use. PLA nanoparticles (PLA-NPs) conjugated with 5-fluorouracil (5-FU) were synthesized using different molecular weights and concentrations of PLA to control particle size. Ex vivo permeation research was performed on excised corneas from rabbits and goats. In vivo tests were performed on rabbit eyes, and 5-FU concentrations were quantified in vitreous and aqueous humor by HPLC. In vitro assays demonstrated that 5-FU was delivered in a diffusion-controlled manner. No notable interaction was seen between mucin and PLA nanoparticles, as assessed by viscosity alterations. Compared to goat corneas, rabbit corneas had a considerably higher ex vivo penetration rate. PLA and CH-PLA DNPs demonstrated an enhanced amount of 5-FU compared to the 5-FU solution. In vivo investigations indicated considerably larger concentrations of CH-coated and uncoated PLA nanoparticles in the eyes of rabbits as compared to a free 5-FU solution. PLA nanoparticles were determined to be non-irritant in nature via an adjusted Draize test.
Zhou et al. 346 construct a self-aggregated nanoparticle carrier employing an amphiphilic blend of poly(lactic acid), chitosan (PLA-g-CS), and test its efficacy for ophthalmic administration of amphotericin B (AmB). A PLA-g-CS copolymer was manufactured by a “protection-graft-deprotection” method. Amphotericin B-loaded nanoparticles formulated from PLA-g-CS (AmB/PLA-g-CS) were synthesized via the dialysis method. Investigations of these AmB/PLA-g-CS nanoparticles, including their mucoadhesive strength, antifungal activity, drug release properties, ocular irritation, corneal penetration, and ocular pharmacokinetics, were performed in vivo and in vitro. The self-assembled PLA-g-CS nanoparticles showed a core-shell construction, with an average particle size of about 200 nm and a zeta potential above 30 mV. With a high encapsulation effectiveness, amphotericin B was integrated into the hydrophobic core of the nanoparticles. In vitro, sustained drug release from the nanoparticles was seen. The ocular irritation investigation showed no irritation sign after application of the PLA-g-CS nanoparticles into rabbit eyes. The AmB/PLA-g-CS nanoparticles exhibited antifungal efficacy against Candida albicans comparable to that of free amphotericin B at the least inhibitory concentration. An advantage of PLA-g-CS nanoparticles, according to the in vivo ocular pharmacokinetic investigation, is that they have a longer residence period at the ocular surface. The corneal penetration investigation revealed that the PLA-g-CS nanoparticles were capable of penetrating the cornea. Their findings indicate that this nanoparticulate vehicle, developed from a PLA-g-CS copolymer, may serve as an appropriate strategy for the efficient ocular administration of AmB.
Poly (D, L-lactide-co-glycolide) (PLGA)-based nanoparticles
PLGA is an FDA-approved biocompatible and biodegradable polymer for ophthalmic use, showing significant potential in ocular drug delivery applications owing to its sustained-release properties. PLGA undergoes hydrolysis in the organism, producing glycolic acid and lactic acid, both of which are endogenous and metabolized via the citric acid cycle (Krebs cycle). The stereochemistry of lactic acid (L, D, or DL), the lactic acid/glycolic acid ratio, the molecular weight, and the degree of crystallinity all affect the properties of these copolymers. PLGA copolymers with a lactide-to-glycolide ratio of 50:50 show a satisfactory balance of hydrophilic and lipophilic properties, as well as satisfactory rates of degradation. Adding a stabilizer, like polyvinyl alcohol (PVA), is a common way to make PLGA nanoparticles that are uniform and can be redispersed.
The therapeutic agents’ encapsulation into PLGA nanocarriers can enhance efficiency and improve bioavailability. Drug-loaded PLGA nanoparticles offer advantages in topical formulations for eye diseases, including enhanced transit of weakly water-soluble chemicals, prolonged corneal retention period of active drugs, and improved drug penetration.
PLGA NPs are often used for sustained drug delivery systems owing to their beneficial properties, including facile metabolism of PLGA monomers via the Krebs cycle in the body, prolonged degradation kinetics, and their potential to circumvent P-glycoprotein efflux, hence increasing corneal drug penetration. The drug release profile and following dosage schedules can be readily modified. PLGA NPs are absorbed in cells by clathrin-mediated endocytosis and fluid phase pinocytosis, escaping endolysosomes rapidly and entering the cytoplasm. The reticuloendothelial system, or RE, removes NPs from the circulation.
Vega et al. 347 formulated FB in PLGA NPs and obtained excellent stability and adequate physicochemical qualities for ocular delivery without producing ocular irritation at any capacity.
Abhishek K. Sah et al. 348 develop loteprednol etabonate (LE)-loaded PLGA nanoparticles (NPs) and analyze their penetration characteristics into the resected goat cornea. The high-speed homogenization technique was employed to produce LE-loaded PLGA NPs through solvent evaporation. Rhodamine (Rd) was utilized as a fluorescent indicator to create Rd-LE–PLGA-NPs. The observed intense fluorescence in the recesses of goat corneal tissue indicated that the penetration profile of NPs had been enhanced. The mean diameter and entrapment efficiency of the improved formulation (F5) were determined to be 167.6 ± 0.37 nm and 96.31 ± 1.68%, respectively. The results suggest that LE-loaded PLGA nanoparticles may function as a viable drug carrier for ocular delivery in eye diseases.
Gebreel et al. 349 develop hydrogels infused with nanoparticles (NPs) and norfloxacin (NFX) to enhance ocular absorption of NFX, decrease the frequency of instillations, and mitigate side effects. NFX-loaded nanoparticles were synthesized using the double-emulsion/solvent evaporation method using two types of PLGA polymer and four (drug:polymer) ratios. Two formulas were analytically chosen and integrated into hydroxypropyl methylcellulose (HPMC)-based hydrogels: G1-G4. The chosen nanoparticles (NP2 and NP6) exhibited a spherical morphology and showed appropriate particle sizes of 392.02 nm and 190.51 nm, along with polydispersity indices of 0.17 and 0.18. They also demonstrated high EE% (79.24% and 91.72%), high magnitude of ZP (−30.43 mV and −33.62 mV), and low percentages at 30 min (10.96% and 16.65%) for Q and (17.39% and 21.05%) for P. Furthermore, they displayed encouraging percentages at 12 h, with Q values of 58.23% and 71.20% and P values of 53.31% and 65.01%, respectively. Clear, tolerable, spreadable, thixotropic, and pseudoplastic hydrogels based on HPMC have been established. The findings indicated a prolonged period of pharmaceutical release and enhanced drug penetration characteristics. The hydrogels loaded with NP2 and NP6 (G3 and G4 systems, respectively) demonstrated notable antibacterial efficacy as well as adequate histopathological safety profiles. G3 and G4 serve as promising ways to deliver NFX to the eyes.
Vasconcelos et al. 350 conjugated a peptide for ocular delivery (POD) and the human immunodeficiency virus transactivator that is biodegradable and composed of PGLA–polyethylene glycol (PEG) nanoparticles (NPs) to enhance bioavailability of ocular drugs. The nanoparticles were synthesized utilizing the solvent displacement technique via two distinct approaches. One approach entailed the preparation of PLGA nanoparticles, followed by the conjugation of peptide and PEG (PLGA-NPs-PEG-peptide); the other method focused on the self-assembly of PLGA-PEG and the PLGA-PEG-peptide copolymer, subsequently leading to nanoparticle formulation. The anti-inflammatory efficacy in vivo was evaluated in rabbit eyes following the topical application of sodium arachidonate. Among the devised formulations, the PLGA-PEG-POD NPs were the smallest particles, demonstrating higher entrapment efficiency and an additional sustained release profile. The positive charge on the surface of these nanoparticles, which came from their connection to a positively charged peptide, made it easier for them to pass through the corneal epithelium. This helped prevent eye inflammation even more. The established nanoparticles exhibited minimal in vitro toxicity, with no ocular irritation detected either in vitro (hen’s egg test–chorioallantoic membrane examination) or in vivo (Draize test). The results suggest that PLGA-PEG-POD nanoparticles are strong candidates for drug delivery systems that work well in the eyes.
Polyethylene glycol (PEG)-based nanoparticles
Polyethylene glycol (PEG) is a hydrophilic, nonionic polymer known for its exceptional biocompatibility. There are many ways to add it to nanoparticles, such as covalent binding, mixing during nanoparticle preparation, and adsorption on the surface. The existence of PEG on the surface of nanoparticles may confer additional benefits, including an enhancement of their systemic circulation half-life and improved mucoadhesion.
Using a hydrophilic copolymer called poly(ethylene glycol)-b-p(hydroxypropyl) methacrylamide (mPH), Sanjay Ch et al. 351 made moxifloxacin-encapsulated co-polymeric nanoparticles (NPs). The polymer (mPH) was synthesized through a radical polymerization method, utilizing various mPEG:HPMA ratios of 1:70, 1:100, and 1:150. A texture analyzer and Franz diffusion cells were used to evaluate the ex vivo muco-adhesiveness as well as the corneal penetration ability. The DOE-optimized colloidal suspension of Mox-mPH nanoparticles (1:150) exhibited a particle size of approximately 116 nm, demonstrating enhanced drug loading (8.3%), strong mucoadhesion ex vivo, entrapment (83.2%), and ocular retention in vivo (∼6 h), as assessed through vivo image analysis. The Mox-mPH nanoparticles (1:150) formulation, which doesn’t cause irritation (as shown by the HET-CAM test), showed strong antimicrobial activity against S. pneumoniae, P. aeruginosa, and S. aureus in vitro, as shown by zone of inhibition studies, live-dead cell assays, and the determination of minimum levels of bactericidal and inhibitory agents. The polymeric nanoparticles, mPH (1:150), demonstrated a reduction in bacterial load and opacity in contrast to the other groups receiving treatment. The findings support the effective and safe use of the Mox-mPH NPs solution for topical application in cases of bacterial keratitis.
In an effort to inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis and suppress experimental corneal neovascularization, Lee et al. 352 investigate the application of nanoparticles for the delivery of apatinib, a unique and targeted antagonist of the VEGF receptor. Apatinib, which is not soluble in water, was encapsulated within nanoparticles made from polyethylene glycol (PEG) that is conjugated with human serum albumin (HSA). Assays for in vitro angiogenesis demonstrated that apatinib-loaded HSA-PEG (Apa-HSA-PEG) nanoparticles effectively inhibited VEGF-induced tube development, the proliferation of human endothelial cells, and scratch wound migration. A subconjunctival injection of Apa-HSA-PEG nanoparticles resulted in a significant decrease in neovascularization in a rat model of corneal neovascularization induced by alkali burn injury. This diminution was in comparison to the neovascularization that was detected with an injection of phosphate-buffered saline or free apatinib solution. An in vivo investigation utilizing HSA-PEG nanoparticles infused with fluorescent hydrophobic molecules demonstrated substantial accumulation of nanoparticles in the corneal stroma within a 24-h period of injection. Data from both in vitro and in vivo studies indicates that apatinib-loaded nanoparticles may serve as an exciting option for the prophylaxis and management of ocular conditions related to corneal neovascularization.
Pre-clinical testing: From in vitro to in vivo models
Pre-clinical trials usually advance through in vitro cellular through ex vivo tissue to in vivo animal studies. During in vitro studies, cytotoxicity, proliferation, and wound healing are examined using cultivated corneal epithelial, endothelial or stromal cells. This phase provides extensive control, but has no systemic immune response. The ex-vivo stage consists of human or animal corneas in the form of whole globes or with corneal rims for assessing tissue regeneration, transparency and drug penetration. This method is structurally protective and ethically conservative while tissue viability is restricted and there are no systemic immune-responses. Lastly, in vivo animal models are used to investigate corneal regeneration, transparency, immunity as well as drug pharmacokinetics. These models offer a complete physiological and immune framework, although these usually feature higher costs, diverse species dependence and ethical restrictions.
Ex vivo corneal culture models
Overview of recent ex vivo and organ culture corneal models highlighting their design principles, applications in wound healing, infection, and endothelial studies, and corresponding cell or tissue sources.
In vivo assessment in animal models of corneal injury
Analysis of corneal regeneration, transparency, and immune response in animal models is an important step in pre-clinical tests for ocular therapies. In vivo research offers the possibility of studying corneal healing biological events in an intact physiological setting, which involves interactions between epithelial, stromal and endothelial cells as well as from nerves, tear film and immune elements. Such studies are suitable for experiments across several animal models but predominantly on rabbits, rats and mice primarily because of the size of the cornea and due to its ease in handling and organized ocular anatomy, respectively. Corneal damage is usually achieved through mechanical debridement, chemical burns thereof or laser ablations. After injury it is possible to apply the therapeutic strategies including cell therapy, biomaterial scaffolds and pharmacological agents. The animals are followed over time to analyze corneal wound healing, re-epithelialization and stromal remodeling. These evaluations are confirmed by histology, molecular and imaging approaches for a more complete understanding of the healing response.
Evaluating regeneration, transparency, and immune response
Regeneration: Corneal re-epithelialization, stromal repair and corneal thickness restoration are used to measure the degree of regeneration. Imaging techniques that include slit-lamp biomicroscope, optical coherence tomography (OCT) and fluorescein staining permit visualization of epithelial integrity and stromal remodeling. Histological analysis and immunohistochemical evaluation are also used in the evaluation of corneal regeneration.365,366
Transparency: Corneal transparency is an important criterion to evaluate functional recovery. Clinically, it can be assessed by slit-lamp examination, measuring light transmission and haze scoring. Quantitative techniques such as in vivo confocal microscopy and densitometry to analyse corneal images taken allow for objective measurement of opacity.367,368
In vivo assessment of corneal regeneration, transparency, and immune response.
Conclusion and future perspectives
In summary, nanotechnology has made a lot of progress in corneal tissue engineering by giving us new ways to resolve important problems in corneal repair and restoration. Nanomaterials, such as nanofibers and nanoparticles, make corneal scaffolds stronger, clearer, and more permeable. They also make it easier to deliver drugs to specific areas to treat inflammation, infections, and new blood vessel growth. Electrospinning is a useful way to make nanofibers that look a lot like the natural extracellular matrix (ECM) of living things. This makes it easier for cells to stick together, grow, and integrate into tissues. The combination of synthetic and natural polymers with composite nanoparticles makes it possible to create biocompatible and biodegradable scaffolds that can be tailored to specific corneal conditions. The combination of natural, synthetic, and composite nanoparticles has a lot of potential to make corneal therapies work better. Nanotechnology-based solutions have the capacity to revolutionize scaffold design and enable more accurate treatments, thereby propelling regenerative medicine forward and improving outcomes for patients with corneal injuries and diseases. For corneal tissue engineering to fully benefit from these new technologies, more research and better use in the clinic are needed.
Although major advances, many challenges exist before nanotechnology-based corneal substitutes can be implemented in standard clinical practice. Ensuring permanent biocompatibility, obtaining controlled degradation rates, and preserving uniform optical clarity under physiological conditions are essential domains which need more improvement. The intricate structure of the cornea, made up of various cell types and layers, requires the creation of multi-layered and gradient-structured scaffolds that can replicate the functionality of native tissue. Hybrid materials that integrate the mechanical robustness of synthetic polymers with the biological functionality of natural biopolymers present an option for completing such a balance.
Future studies should focus on the fusion of nanotechnology with emerging fields such as bioprinting, stem cell therapy, and bioactive surface modification to develop patient-specific corneal structures. The combination of nanofabrication techniques with intelligent, stimulus-responsive polymers might produce scaffolds that independently react to the ocular environment, facilitating the regulated delivery of therapeutic agents or altering their physical properties in response to tissue remodeling. Furthermore, the utilization of decellularized and customized nanostructures may promote the creation of scaffolds exhibiting improved cellular compatibility and regeneration potential.
In conclusion, approaches derived from nanotechnology demonstrate considerable potential for the regeneration of functional, transparent, and elastic corneal tissue. Multidisciplinary studies are integrating material science with clinical eye care, advancing the development of functional artificial corneas that can restore vision and improve the quality of life for millions globally.
Footnotes
Acknowledgements
The authors thank DeepSeek, an advanced artificial intelligence platform, for helping them improve the language and make the manuscript clearer. The authors are fully responsible for the intellectual content and scientific contributions, and they thank DeepSeek for helping to improve the editorial process.
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The present study was supported by Shahroud University of medical sciences, Shahroud, Iran (Grant No. 14030085).
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
